{
"RECORDS":[
{
"Name":"Prostate Carcinoma",
"Definition":"One of the most common malignant tumors afflicting men. The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Gros",
"Synonmys":"Cancer of Prostate\nCancer of the Prostate\nCarcinoma of Prostate\nCarcinoma of the Prostate\nProstate Cancer\nprostate cancer\nProstate cancer, NOS\nProstate Carcinoma",
"NCI_code":"NCI Thesaurus Code: C4863"
},
{
"Name":"Epidemiological aspects of prostate cancer",
"Definition":"The study of the causes, incidence and distribution of disease in the population and its application for prevention or control",
"Synonmys":"Epidemiologic\nEpidemiological\nepidemiology\nEpidemiology",
"NCI_code":"NCI Thesaurus Code:  C16556"
},
{
"Name":"Basic information of patient",
"Definition":"A file containing demographic, medical, and treatment information pertaining to an individual patient.",
"Synonmys":"Patient information\npatient file\nPatient File",
"NCI_code":"BioPortal cui:C2598117"
},
{
"Name":"Age",
"Definition":"How long something has existed; elapsed time since birth.",
"Synonmys":"Age",
"NCI_code":"NCI Thesaurus Code:C25150 "
},
{
"Name":"Occupation",
"Definition":"The principal activity that a person does to earn money.",
"Synonmys":"EMPJOB\nEmployee Job\nJob\nOccupation\nOCCUPATION",
"NCI_code":"NCI Thesaurus Code:C25193"
},
{
"Name":"Race",
"Definition":"An arbitrary classification of a taxonomic group that is a division of a species. ",
"Synonmys":"Racial Group",
"NCI_code":"NCI Thesaurus Code:C17049"
},
{
"Name":"Marital Status",
"Definition":"A demographic parameter indicating a person's current conjugal status.",
"Synonmys":"MARISTAT\nMarital or partnership status\nMarital Status\nMaritalStatusUB92",
"NCI_code":"NCI Thesaurus Code:C25188"
},
{
"Name":"Nationality",
"Definition":"Nationality is a legal relationship between an individual person and a state.",
"Synonmys":"Nationality",
"NCI_code":"NA"
},
{
"Name":"Education Level",
"Definition":"An indication of the years of schooling completed in graded public, private, or parochial schools, and in colleges, universities, or professional schools.",
"Synonmys":"Education\nEducation Level\nEducation Level Completed\nEducational Attainment\nEducational Level\nEDULEVEL\nLevel of Education Attained",
"NCI_code":"NCI Thesaurus Code:C17953"
},
{
"Name":"Personal Medical History",
"Definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.",
"Synonmys":"History\nMedical History\nPast Medical History\npersonal health record\nPersonal History\npersonal history\nPersonal Medical History\npersonal medical history\nPMH",
"NCI_code":"NCI Thesaurus Code:C18772"
},
{
"Name":"Hypertension",
"Definition":"Blood pressure that is abnormally high.",
"Synonmys":"Blood Pressure, High\nBlood Pressure, Increased\nHigh Blood Pressure\nhigh blood pressure\nHigh blood pressure\nHTN\nHypertension\nhypertension\nIncreased Blood Pressure\nPressure, High Blood\nVascular Hyperten",
"NCI_code":"NCI Thesaurus Code:C3117"
},
{
"Name":"Diabetes Mellitus",
"Definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance\/desensitization.",
"Synonmys":"Diabetes\ndiabetes\nDiabetes Mellitus\ndiabetes mellitus\nDM",
"NCI_code":"NCI Thesaurus Code:C2985 "
},
{
"Name":"Coronary Artery Disease",
"Definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls.",
"Synonmys":"CAD\ncoronary artery disease\nCoronary Artery Disease\nCoronary Disease\ncoronary heart disease",
"NCI_code":"NCI Thesaurus Code:C26732"
},
{
"Name":"Hyperlipidemia",
"Definition":"Elevated levels of lipids in the blood.",
"Synonmys":"Hyperlipidemia",
"NCI_code":"NCI Thesaurus Code:  C34707"
},
{
"Name":"Osteoporosis",
"Definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased",
"Synonmys":"Osteoporosis\nosteoporosis",
"NCI_code":"NCI Thesaurus Code:C3298"
},
{
"Name":"Genetic and epigenetic of prostate cancer",
"Definition":"Cancer epigenetics is the study of epigenetic modifications to the DNA of cancer cells that do not involve a change in the nucleotide sequence.",
"Synonmys":"Genetic and epigenetic of prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Gene",
"Definition":"In biology, a gene is a sequence of DNA or RNA that codes for a molecule that has a function. During gene expression, the DNA is first copied into RNA. The RNA can be directly functional or be the int",
"Synonmys":"Gene",
"NCI_code":"NA"
},
{
"Name":"AGA2 Alopecia, androgenetic, 2",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: Xq11-q12"
},
{
"Name":"AGA3 Alopecia, androgenetic, 3",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: 20p11.22"
},
{
"Name":"AKT1 AKT serine\/threonine kinase 1",
"Definition":"The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derive",
"Synonmys":"AKT; PKBRAC; CWS6; PRKBA; PKB-ALPHA; RAC-ALPHA",
"NCI_code":"Location: 14q32.33"
},
{
"Name":"AR androgen receptor",
"Definition":"The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein func",
"Synonmys":"KD; AIS; AR8; TFM; DHTR; SBMA; HYSP1; NR3C4; SMAX1; HUMARA",
"NCI_code":"Location: Xq12;  Sequence: Chromosome: X;   NC_000023.11 (67544623..67730619)"
},
{
"Name":"ATM ATM serine\/threonine kinase",
"Definition":"The protein encoded by this gene belongs to the PI3\/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variet",
"Synonmys":"AT1; ATA; ATC; ATD; ATE; ATDC; TEL1; TELO1",
"NCI_code":"Location: 11q22.3;  Sequence: Chromosome: 11;   NC_000011.10 (108222484..108369099)"
},
{
"Name":"BARD1 BRCA1 associated RING domain 1",
"Definition":"This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of ",
"Synonmys":"NA",
"NCI_code":"Location: 2q35;  Sequence: Chromosome: 2;   NC_000002.12 (214725645..214809711, complement)"
},
{
"Name":"BRCA1 BRCA1, DNA repair associated",
"Definition":"This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA da",
"Synonmys":"IRIS; PSCP; BRCAI; BRCC1; FANCS; PNCA4; RNF53; BROVCA1; PPP1R53",
"NCI_code":"Location: 17q21.31;  Sequence: Chromosome: 17;   NC_000017.11 (43044295..43125483, complement)"
},
{
"Name":"BRCA2 BRCA2, DNA repair associated",
"Definition":"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specific",
"Synonmys":"FAD; FACD; FAD1; GLM3; BRCC2; FANCD; PNCA2; FANCD1; XRCC11; BROVCA2",
"NCI_code":"Location: 13q13.1;  Sequence: Chromosome: 13;   NC_000013.11 (32315480..32399672)"
},
{
"Name":"BRIP1 BRCA1 interacting protein C-terminal helicas",
"Definition":"The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-",
"Synonmys":"OF; BACH1; FANCJ",
"NCI_code":"Location: 17q23.2;  Sequence: Chromosome: 17;   NC_000017.11 (61679186..61864120, complement)"
},
{
"Name":"CASP8 caspase 8",
"Definition":"This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as i",
"Synonmys":"CAP4; MACH; MCH5; FLICE; ALPS2B; Casp-8",
"NCI_code":"Location: 2q33.1;  Sequence: Chromosome: 2;   NC_000002.12 (201233443..201287711)"
},
{
"Name":"CD82 CD82 molecule",
"Definition":"This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression ",
"Synonmys":"R2; 4F9; C33; IA4; ST6; GR15; KAI1; SAR2; TSPAN27",
"NCI_code":"Location: 11p11.2;  Sequence: Chromosome: 11;   NC_000011.10 (44565591..44620363)"
},
{
"Name":"CDH1 cadherin 1",
"Definition":"This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically ",
"Synonmys":"UVO; CDHE; ECAD; LCAM; Arc-1; BCDS1; CD324",
"NCI_code":"Location: 16q22.1;  Sequence: Chromosome: 16;   NC_000016.10 (68737290..68835542)"
},
{
"Name":"CHEK2 checkpoint kinase 2",
"Definition":"In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint re",
"Synonmys":"CDS1; CHK2; LFS2; RAD53; hCds1; HuCds1; PP1425",
"NCI_code":"Location: 22q12.1;  Sequence: Chromosome: 22;   NC_000022.11 (28687743..28741866, complement)"
},
{
"Name":"EHBP1 EH domain binding protein 1",
"Definition":"This gene encodes an Eps15 homology domain binding protein. The encoded protein may play a role in endocytic trafficking. A single nucleotide polymorphism in this gene is associated with an aggressive",
"Synonmys":"HPC12; NACSIN",
"NCI_code":"Location: 2p15;  Sequence: Chromosome: 2;   NC_000002.12 (62673851..63046487)"
},
{
"Name":"ELAC2 elaC ribonuclease Z 2",
"Definition":"The protein encoded by this gene has a C-terminal domain with tRNA 3&#8242; processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also i",
"Synonmys":"ELC2; HPC2; COXPD17",
"NCI_code":"Location: 17p12;  Sequence: Chromosome: 17;   NC_000017.11 (12991612..13018064, complement)"
},
{
"Name":"EPHB2 EPH receptor B2",
"Definition":"This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a trans",
"Synonmys":"DRT; EK5; ERK; CAPB; Hek5; PCBC; EPHT3; Tyro5",
"NCI_code":"Location: 1p36.12;  Sequence: Chromosome: 1;   NC_000001.11 (22710770..22921500)"
},
{
"Name":"ESR1 estrogen receptor 1",
"Definition":"This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein loc",
"Synonmys":"ER; ESR; Era; ESRA; ESTRR; NR3A1",
"NCI_code":"Location: 6q25.1-q25.2;  Sequence: Chromosome: 6;   NC_000006.12 (151654148..152129604)"
},
{
"Name":"HIP1 huntingtin interacting protein 1",
"Definition":"The product of this gene is a membrane-associated protein that functions in clathrin-mediated endocytosis and protein trafficking within the cell. The encoded protein binds to the huntingtin protein i",
"Synonmys":"SHON; HIP-I; ILWEQ; SHONbeta; SHONgamma",
"NCI_code":"Location: 7q11.23;  Sequence: Chromosome: 7;   NC_000007.14 (75533298..75738976, complement)"
},
{
"Name":"HMMR hyaluronan mediated motility receptor",
"Definition":"The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associate",
"Synonmys":"CD168; IHABP; RHAMM",
"NCI_code":"Location: 5q34;  Sequence: Chromosome: 5;   NC_000005.10 (163460511..163491945)"
},
{
"Name":"HPC10 Prostate cancer, hereditary, 10",
"Definition":"Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.\nGenome-wide association study identifies a second prostate cancer susceptibility ",
"Synonmys":"NA",
"NCI_code":"Location: 8q24"
},
{
"Name":"HPC14 Prostate cancer, hereditary, 14",
"Definition":"Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.\nMultiple loci identified in a genome-wide association study of prostate cancer.\nM",
"Synonmys":"NA",
"NCI_code":"Location: 11q13"
},
{
"Name":"HPC15 Prostate cancer, hereditary, 15",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: 19q13.4"
},
{
"Name":"HPC3 Prostate cancer, hereditary, 3",
"Definition":"Evidence for a prostate cancer-susceptibility locus on chromosome 20.\nPredicting prostate cancer risk through incorporation of prostate cancer gene 3.\nUtility of incorporating genetic variants for the",
"Synonmys":"HPC20",
"NCI_code":"Location: 20q13"
},
{
"Name":"HPC4 Prostate cancer, hereditary, 4",
"Definition":"Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.",
"Synonmys":"HPC7",
"NCI_code":"Location: 7p11-q21"
},
{
"Name":"HPC5 prostate cancer, hereditary, 5",
"Definition":"Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.",
"Synonmys":"NA",
"NCI_code":"Location: 3p26"
},
{
"Name":"HPC6 Prostate cancer, susceptibility to",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: 22q12.3"
},
{
"Name":"HPC7 Prostate cancer, hereditary, 7",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: 15q12"
},
{
"Name":"HPC9 Prostate cancer, hereditary, 9",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: 17q21-q22"
},
{
"Name":"HPCQTL19 Prostate cancer aggressiveness quantitati",
"Definition":"Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q.",
"Synonmys":"NA",
"NCI_code":"Location: 19q"
},
{
"Name":"HPCX hereditary prostate cancer, X-linked",
"Definition":"A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer.\nGenetic linkage analysis of prostate cancer families to Xq27-28.\nEvidence for a prostate cancer susceptibility locus on the ",
"Synonmys":"NA",
"NCI_code":"Location: Xq27-q28"
},
{
"Name":"HPCX2 Prostate cancer, hereditary, X-linked 2",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"Location: Xp11.22"
},
{
"Name":"KLF6 Kruppel like factor 6",
"Definition":"This gene encodes a member of the Kruppel-like family of transcription factors. The zinc finger protein is a transcriptional activator, and functions as a tumor suppressor. Multiple transcript variant",
"Synonmys":"GBF; ZF9; BCD1; CBA1; CPBP; PAC1; ST12; COPEB",
"NCI_code":"Location: 10p15.2;  Sequence: Chromosome: 10;   NC_000010.11 (3775996..3785281, complement)"
},
{
"Name":"KRAS KRAS proto-oncogene, GTPase",
"Definition":"This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an",
"Synonmys":"NS; NS3; CFC2; RALD; K-Ras; KRAS1; KRAS2; RASK2; KI-RAS; C-K-RAS; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; c-Ki-ras2",
"NCI_code":"Location: 12p12.1;  Sequence: Chromosome: 12;   NC_000012.12 (25204789..25251003, complement)"
},
{
"Name":"MAD1L1 mitotic arrest deficient 1 like 1",
"Definition":"MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer a",
"Synonmys":"MAD1; PIG9; TP53I9; TXBP181",
"NCI_code":"Location: 7p22.3;  Sequence: Chromosome: 7;   NC_000007.14 (1815792..2232971, complement)"
},
{
"Name":"MSMB microseminoprotein beta",
"Definition":"The protein encoded by this gene is a member of the immunoglobulin binding factor family. It is synthesized by the epithelial cells of the prostate gland and secreted into the seminal plasma. This pro",
"Synonmys":"MSP; PSP; IGBF; MSPB; PN44; PRPS; HPC13; PSP57; PSP94; PSP-94",
"NCI_code":"Location: 10q11.22;  Sequence: Chromosome: 10;   NC_000010.11 (46033305..46046269, complement)"
},
{
"Name":"MSR1 macrophage scavenger receptor 1",
"Definition":"This gene encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of this gene. These receptors or isoforms are macrophage-s",
"Synonmys":"SRA; SR-A; CD204; SR-AI; phSR1; phSR2; SCARA1; SR-AII; SR-AIII",
"NCI_code":"Location: 8p22;  Sequence: Chromosome: 8;   NC_000008.11 (16107878..16192791, complement)"
},
{
"Name":"MXI1 MAX interactor 1, dimerization protein",
"Definition":"Expression of the c-myc gene, which produces an oncogenic transcription factor, is tightly regulated in normal cells but is frequently deregulated in human cancers. The protein encoded by this gene is",
"Synonmys":"MXI; MAD2; MXD2; bHLHc11",
"NCI_code":"Location: 10q25.2;  Sequence: Chromosome: 10;   NC_000010.11 (110207605..110287365)"
},
{
"Name":"NQO2 N-ribosyldihydronicotinamide:quinone reductas",
"Definition":"This gene encodes a member of the thioredoxin family of enzymes. It is a cytosolic and ubiquitously expressed flavoprotein that catalyzes the two-electron reduction of quinone substrates and uses dihy",
"Synonmys":"QR2; DHQV; DIA6; NMOR2",
"NCI_code":"Location: 6p25.2;  Sequence: Chromosome: 6;   NC_000006.12 (2999816..3019876)"
},
{
"Name":"PALB2 partner and localizer of BRCA2",
"Definition":"This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the st",
"Synonmys":"FANCN; PNCA3",
"NCI_code":"Location: 16p12.2;  Sequence: Chromosome: 16;   NC_000016.10 (23603162..23641357, complement)"
},
{
"Name":"PCAP predisposing for prostate cancer",
"Definition":"PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.\nPredisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.\nCGI-55 interact",
"Synonmys":"HPC2; HPC8",
"NCI_code":"Location: 1q42.2-q43"
},
{
"Name":"PHB prohibitin",
"Definition":"This gene is evolutionarily conserved, and its product is proposed to play a role in human cellular senescence and tumor suppression. Antiproliferative activity is reported to be localized to the 3' U",
"Synonmys":"PHB1; HEL-215; HEL-S-54e",
"NCI_code":"Location: 17q21.33;  Sequence: Chromosome: 17;   NC_000017.11 (49404048..49414905, complement)"
},
{
"Name":"PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kin",
"Definition":"Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphor",
"Synonmys":"MCM; CWS5; MCAP; PI3K; CLOVE; MCMTC; PI3K-alpha; p110-alpha",
"NCI_code":"Location: 3q26.32;  Sequence: Chromosome: 3;   NC_000003.12 (179148114..179240093)"
},
{
"Name":"PPM1D protein phosphatase, Mg2+\/Mn2+ dependent 1D",
"Definition":"The protein encoded by this gene is a member of the PP2C family of Ser\/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. The expressio",
"Synonmys":"WIP1; IDDGIP; PP2C-DELTA",
"NCI_code":"Location: 17q23.2;  Sequence: Chromosome: 17;   NC_000017.11 (60600183..60666280)"
},
{
"Name":"PTEN phosphatase and tensin homolog",
"Definition":"This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphat",
"Synonmys":"BZS; DEC; CWS1; GLM2; MHAM; TEP1; MMAC1; PTEN1; 10q23del; PTENbeta",
"NCI_code":"Location: 10q23.31;  Sequence: Chromosome: 10;   NC_000010.11 (87863438..87971930)"
},
{
"Name":"RAD51 RAD51 recombinase",
"Definition":"The protein encoded by this gene is a member of the RAD51 protein family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51, and are known to be involved in ",
"Synonmys":"RECA; BRCC5; FANCR; MRMV2; HRAD51; RAD51A; HsRad51; HsT16930",
"NCI_code":"Location: 15q15.1;  Sequence: Chromosome: 15;   NC_000015.10 (40694774..40732340)"
},
{
"Name":"RAD54L RAD54 like",
"Definition":"The protein encoded by this gene belongs to the DEAD-like helicase superfamily, and shares similarity with Saccharomyces cerevisiae Rad54, a protein known to be involved in the homologous recombinatio",
"Synonmys":"HR54; hHR54; RAD54A; hRAD54",
"NCI_code":"Location: 1p34.1;  Sequence: Chromosome: 1;   NC_000001.11 (46247695..46278477)"
},
{
"Name":"RB1CC1 RB1 inducible coiled-coil 1",
"Definition":"The protein encoded by this gene interacts with signaling pathways to coordinately regulate cell growth, cell proliferation, apoptosis, autophagy, and cell migration. This tumor suppressor also enhanc",
"Synonmys":"CC1; ATG17; FIP200; PPP1R131",
"NCI_code":"Location: 8q11.23;  Sequence: Chromosome: 8;   NC_000008.11 (52622458..52714466, complement)"
},
{
"Name":"RNASEL ribonuclease L",
"Definition":"This gene encodes a component of the interferon-regulated 2-5A system that functions in the antiviral and antiproliferative roles of interferons. Mutations in this gene have been associated with predi",
"Synonmys":"RNS4; PRCA1",
"NCI_code":"Location: 1q25.3;  Sequence: Chromosome: 1;   NC_000001.11 (182573634..182589285, complement)"
},
{
"Name":"SLC22A18 solute carrier family 22 member 18",
"Definition":"This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been",
"Synonmys":"HET; ITM; BWR1A; IMPT1; TSSC5; ORCTL2; BWSCR1A; SLC22A1L; p45-BWR1A",
"NCI_code":"Location: 11p15.4;  Sequence: Chromosome: 11;   NC_000011.10 (2899721..2925246)"
},
{
"Name":"TP53 tumor protein p53",
"Definition":"This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expr",
"Synonmys":"P53; BCC7; LFS1; TRP53",
"NCI_code":"Location: 17p13.1;  Sequence: Chromosome: 17;   NC_000017.11 (7668402..7687550, complement)"
},
{
"Name":"TSG101 tumor susceptibility 101",
"Definition":"The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cyt",
"Synonmys":"TSG10; VPS23",
"NCI_code":"Location: 11p15.1;  Sequence: Chromosome: 11;   NC_000011.10 (18480311..18526956, complement)"
},
{
"Name":"XRCC3 X-ray repair cross complementing 3",
"Definition":"This gene encodes a member of the RecA\/Rad51-related protein family that participates in homologous recombination to maintain chromosome stability and repair DNA damage. This gene functionally complem",
"Synonmys":"CMM6",
"NCI_code":"Location: 14q32.33;  Sequence: Chromosome: 14;   NC_000014.9 (103697611..103715486, complement)"
},
{
"Name":"ZFHX3 zinc finger homeobox 3",
"Definition":"This gene encodes a transcription factor with multiple homeodomains and zinc finger motifs, and regulates myogenic and neuronal differentiation. The encoded protein suppresses expression of the alpha-",
"Synonmys":"ATBT; ATBF1; ZNF927",
"NCI_code":"Location: 16q22.2-q22.3;  Sequence: Chromosome: 16;   NC_000016.10 (72782885..73058635, complement)"
},
{
"Name":"Copy Number Polymorphism",
"Definition":"Definition: Variation in the number of copies of a particular sequence within the genetic material of an individual. Large-scale copy number polymorphisms are common and widely distributed in the huma",
"Synonmys":"CNA\nCNP\nCNV\nCopy Number Alteration\nCopy Number Polymorphism\ncopy number variant\nCopy Number Variation",
"NCI_code":"NCI Thesaurus Code:  C40207"
},
{
"Name":"Single-nucleotide polymorphism",
"Definition":"Definition:  A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding populat",
"Synonmys":"Polymorphism, Single Base\nPolymorphism, Single Nucleotide\nsingle nucleotide polymorphism\nSingle Nucleotide Polymorphism\nSNP",
"NCI_code":"NCI Thesaurus Code:  C18279"
},
{
"Name":"Ribonucleic Acid",
"Definition":"efinition:  Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.\nCDISC Definition",
"Synonmys":"Ribonucleic Acid\nRibonucleic acid\nribonucleic acid\nRNA",
"NCI_code":"NCI Thesaurus Code:  C812"
},
{
"Name":"Lifestyles of prostate cancer",
"Definition":"NA",
"Synonmys":"Lifestyles of prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Demographic characteristics ",
"Definition":"The statistical characterization of human populations or segments of human populations (e.g., characterization by age, sex, race, or income).",
"Synonmys":"Demographic Factor\nDemographic Factors\nDemographics\nDemography\nPopulation Studies \/ Demography",
"NCI_code":"NCI Thesaurus Code: C16495"
},
{
"Name":"Family medical history",
"Definition":"NCI-GLOSS Definition: A record of the relationships among family members along with their medical histories. This includes current and past illnesses. A family history may show a pattern of certain di",
"Synonmys":"Epidemiology, Family Medical History\nfamily history\nFamily History\nFamily History of\nfamily medical history\nFamily Medical History",
"NCI_code":"NCI Thesaurus Code: C17726"
},
{
"Name":"Racial differences",
"Definition":"Race refers to a population with common genetic and phenotypic features that separates them from other populations.Ethnicity pertains to the different cultural, socioeconomic, religious properties, in",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Migrant farm worker",
"Definition":"A worker who travels from place to place as an agricultural worker, ususally moving to participate in harvest activities.",
"Synonmys":"Migrant Farm Worker\nMigratory Farm Worker",
"NCI_code":"NCI Thesaurus Code:C85877"
},
{
"Name":"Basic Behavioral Studies in Cancer-Related Behavio",
"Definition":"Basic behavioral studies designed to strengthen the understanding of the determinants and processes that influence cancer-related risk behaviors.",
"Synonmys":"Basic Behavioral Studies in Cancer-Related Behaviors",
"NCI_code":"NCI Thesaurus Code:C15942"
},
{
"Name":"Green\/black\/tea+Tea\/polyphenols ",
"Definition":"Black tea is an infusion of dried leaves from plants of the Theaceae family. Due to the alkaloid caffeine, its main effect is stimulation. Black teas also contain other phytochemicals such as flavonoi",
"Synonmys":"Black Tea\nTea, Black Extract\nGreen Tea",
"NCI_code":"NCI Thesaurus Code:C29871"
},
{
"Name":"Green Tea",
"Definition":"Tea derived from the dried leaves of the plant Camellia sinensis with potential antioxidant, chemopreventive, and lipid-lowering activities. Green tea contains polyphenols that are believed to be resp",
"Synonmys":"Green Tea",
"NCI_code":"NCI Thesaurus Code:C67048"
},
{
"Name":"Black Tea",
"Definition":" Black tea is an infusion of dried leaves from plants of the Theaceae family. Due to the alkaloid caffeine, its main effect is stimulation. Black teas also contain other phytochemicals such as flavono",
"Synonmys":"Black Tea\nTea, Black Extract",
"NCI_code":"NCI Thesaurus Code:C29871"
},
{
"Name":"Green Tea Extract",
"Definition":"A defined, decaffeinated green tea polyphenol mixture isolated from Camellia sinensis, a plant native to Asia, with antiviral and antioxidant activities and potential chemopreventive activity. Green t",
"Synonmys":"Green Tea Extract\ngreen tea extract\nGreen Tea Polyphenols\nTea, Green Extract\nTea, Green, Polyphenols",
"NCI_code":"NCI Thesaurus Code:C2694"
},
{
"Name":"Alcohol",
"Definition":"A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depr",
"Synonmys":"Absolute ethanol\nAbsolute Ethanol\nAlcohol\nalcohol\nALCOHOL\nEthanol\nETHANOL\nEthyl Alcohol\nMethylcarbinol",
"NCI_code":"NCI Thesaurus Code:C2190"
},
{
"Name":"Coffee",
"Definition":"A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory receptors resembles coffee.",
"Synonmys":"COFFEE\nCoffee Flavor",
"NCI_code":"NCI Thesaurus Code:C73380"
},
{
"Name":"Sleep",
"Definition":"A natural and periodic state of rest during which consciousness of the world is suspended.",
"Synonmys":"Sleep",
"NCI_code":"NCI Thesaurus Code: C73425"
},
{
"Name":"Tobacco smoke",
"Definition":"Smoke from burning tobacco(cigarettes,cigars,or pipes)and  exhaled by a smoker. Tobacco smoke contains nicotine, a stimulant, and other biologically active chemicals having carcinogenic properties.\n",
"Synonmys":"Smoke\nTobacco Smoke",
"NCI_code":"NCI Thesaurus Code:C829"
},
{
"Name":"Sex Behavior",
"Definition":"A form of physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and\/or to enjoying the body of someone else; activities associated with sexual intercourse.",
"Synonmys":"Sex\nSex Behavior\nSexual\nSexual Behavior\nSexually",
"NCI_code":"NCI Thesaurus Code:C17127"
},
{
"Name":"Diet style",
"Definition":"The Western-style diet is characterized by its highly processed and refined foods and high contents of sugars, salt, and fat and protein from red meat. It has been recognized as the major contributor ",
"Synonmys":"Diet style",
"NCI_code":"NA"
},
{
"Name":"Leisure time",
"Definition":"Time used for ease and relaxation.",
"Synonmys":"Leisure\nLeisure Time",
"NCI_code":"NCI Thesaurus Code:C86566"
},
{
"Name":"Physical Activity",
"Definition":"Any form of exercise or movement. Physical activity may include planned activity such as walking, running, basketball, or other sports. Physical activity may also include other daily activities such a",
"Synonmys":"Physical Activity",
"NCI_code":"NCI Thesaurus Code:C17708"
},
{
"Name":"Environment",
"Definition":"The totality of surrounding conditions.",
"Synonmys":"Environment\nEnvironmental",
"NCI_code":"NCI Thesaurus Code:C16551"
},
{
"Name":"Acrylamide",
"Definition":"A colorless, odorless, crystalline amide that polymerizes rapidly and can form as a byproduct during the heating of starch-rich foods to high temperatures. Acrylamide is used in the production of poly",
"Synonmys":"2-Propenamide\nACRYLAMIDE\nAcrylamide\nEthylene Carboxamide\nPropenoic Acid Amide\nVinyl Amide",
"NCI_code":"NCI Thesaurus Code:C44329"
},
{
"Name":"Air pollution",
"Definition":"Air pollution is defined as a phenomenon harmful to the ecological system and the normal conditions of human existence and development when some substances in the atmosphere exceed a certain concentra",
"Synonmys":"Polluted air\nContaminated air\nAir pollution (event)",
"NCI_code":"BioPortal cui:C0001873"
},
{
"Name":"Arsenic",
"Definition":" An element with atomic symbol As, atomic number 33, and atomic weight 74.92.\nNCI-GLOSS Definition: A poisonous chemical used to kill weeds and pests. Also used in cancer therapy.",
"Synonmys":"ARSENIC\narsenic\nArsenic\nAs",
"NCI_code":"NCI Thesaurus Code:C28131"
},
{
"Name":"Asbestos insulation",
"Definition":"some houses  were insulated by blowing crushed, loose-fill asbestos (largely amosite with some crocidolite) into roof spaces. Over time, asbestos fibres migrated to other areas such as wall cavities, ",
"Synonmys":"Asbestos insulation",
"NCI_code":"NA"
},
{
"Name":"Bisphenol A",
"Definition":"Bisphenol A (BPA), 2,2-bis(4-hydroxyphenyl) propane, is one of the most utilized industrial chemicals worldwide, with the ability to interfere with\/or mimic estrogenic hormones with associated biologi",
"Synonmys":"Bisphenol A (product)",
"NCI_code":"BioPortal cui:C0053800"
},
{
"Name":"Environmental Exposure",
"Definition":" Exposure to potentially harmful chemical, physical or biological agents via the environment.",
"Synonmys":"Environmental Exposure",
"NCI_code":"NCI Thesaurus Code:C16552"
},
{
"Name":"Pesticide",
"Definition":"Any agent used to control, repel, or kill unwanted organisms.\nNCI-GLOSS Definition: Any substance that is used to kill insects and other pests.",
"Synonmys":"pesticide\nPesticide\nPesticides",
"NCI_code":"NCI Thesaurus Code:C737"
},
{
"Name":"Chlordecone",
"Definition":"A very stable, colorless, odorless, synthetic chlorinated polycyclic hydrocarbon that is a degradation product of Mirex. Chlordecone has been used as an insecticide on bananas, non-bearing citrus tree",
"Synonmys":"CHLORDECONE\nChlordecone\nCompound 1189\nDecachloroketone\nDecachlorooctahydro-1,3,4-metheno-2H-cyclobuta(cd)-pentalen-2-one\nDecachlorooctahydro-kepone-2-one\nDecachlorotetracyclodecanone\nGC-1189\nKepone",
"NCI_code":"NCI Thesaurus Code:C44352"
},
{
"Name":"Greenness",
"Definition":"The fact of being environmentally or ecologically conscious; commitment to environmental conservation. ",
"Synonmys":"Greenness",
"NCI_code":"NA"
},
{
"Name":"Lead metal",
"Definition":"An element with atomic symbol Pb, atomic number 82, and atomic weight 207.2.",
"Synonmys":"LEAD\nLead\nLead Metal\nMetallic Lead\nPb",
"NCI_code":"NCI Thesaurus Code:C44396"
},
{
"Name":"Season",
"Definition":"Any of the four periods into which the year is divided by the equinoxes and solstices.",
"Synonmys":"Season",
"NCI_code":"NCI Thesaurus Code:C94729 "
},
{
"Name":"Ultraviolet Radiation",
"Definition":"The invisible ultraviolet spectrum makes up one specific portion of sunlight. This unique portion accounts for three percent of all solar radiation reaching the earth. UV radiation causes many health ",
"Synonmys":"Radiation, UV\nSun\/Ultra-Violet Rays\nultraviolet radiation\nUltraviolet Radiation\nUV\nUV radiation\nUV Radiation",
"NCI_code":"NCI Thesaurus Code: C17231"
},
{
"Name":"Mineral",
"Definition":"A solid, homogeneous, inorganic substance occurring in nature and having a definite chemical composition.\nNCI-GLOSS Definition: In medicine, a mineral is a nutrient that is needed in small amounts to ",
"Synonmys":"mineral\nMineral\nMinerals",
"NCI_code":"NCI Thesaurus Code:C656"
},
{
"Name":"Selenium",
"Definition":"A nonmetallic chemical element found in trace amounts in human body. Selenium primarily occurs in vivo as selenocompounds, mostly selenoproteins such as glutathione peroxidase and thioredoxin reductas",
"Synonmys":"Se\nSelenium\nSELENIUM\nselenium",
"NCI_code":"NCI Thesaurus Code:C825"
},
{
"Name":"Calcium",
"Definition":"An element with atomic symbol Ca, atomic number 20, and atomic weight 40.08.\nNCI-GLOSS Definition: A mineral needed for healthy teeth, bones, and other body tissues. It is the most common mineral in t",
"Synonmys":"Ca\nCALCIUM\nCalcium\ncalcium\nCalcium (NOS)",
"NCI_code":"NCI Thesaurus Code:C331"
},
{
"Name":"Iron",
"Definition":"An element with atomic symbol Fe, atomic number 26, and atomic weight 55.85.\nNCI-GLOSS Definition: An important mineral the body needs to make hemoglobin, a substance in the blood that carries oxygen ",
"Synonmys":"Fe\niron\nIron\nIRON\nNiferex",
"NCI_code":"NCI Thesaurus Code:C598"
},
{
"Name":"Nutrition, Trace Elements",
"Definition":"Role of trace elements in cancer causation or prevention and in general health",
"Synonmys":"Micronutrients\nNutrition, Trace Elements\nTrace Element Nutrition\nTrace Nutrients",
"NCI_code":"NCI Thesaurus Code:C15605"
},
{
"Name":"Zinc",
"Definition":"Definition: An element with atomic symbol Zn, atomic number 30, and atomic weight 65.39.",
"Synonmys":"Zinc\nZINC\nZn",
"NCI_code":"NCI Thesaurus Code:C948"
},
{
"Name":"Vitamin",
"Definition":"Definition: A group of organic food substances found in animals and plants in small quantities. They must be supplied in diet or dietary supplement and are essential for normal metabolism.\nCRCH Defini",
"Synonmys":"vitamin\nVitamin\nVitamins",
"NCI_code":"NCI Thesaurus Code:C944"
},
{
"Name":"Vitamin A",
"Definition":"NCI-GLOSS Definition: A nutrient that the body needs in small amounts to function and stay healthy. Vitamin A helps in vision, bone growth, reproduction, growth of epithelium (cells that line the inte",
"Synonmys":"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol\nA 313\nAnti-Infective Vitamin\nAnti-Infective vitamin\nAntixerophthalmic Vitamin\nAntixerophthalmic vitamin\nAquasol A\nArovit\nAvi",
"NCI_code":"NCI Thesaurus Code:C938"
},
{
"Name":"Serum retinol",
"Definition":"a biomarker of vitamin A to reflect body stores",
"Synonmys":"Serum retinol",
"NCI_code":"NA"
},
{
"Name":"Carotenoid",
"Definition":"A class of hydrocarbons (carotenes) and their oxygenated derivatives which exhibit chemopreventive properties. Carotenoids are pigments found in green, yellow, and leafy vegetables, and yellow fruits.",
"Synonmys":"carotenoid\nCarotenoid\nCarotenoids\nCarotenoids (NOS)",
"NCI_code":"NCI Thesaurus Code:C351"
},
{
"Name":"Agent orange",
"Definition":"Definition: Code name for a synthetic defoliant developed for military use. Agent Orange is a mixture of two chemicals, 2,4, dichlorophenoxyacetic acid (2,4-D) and 2,4,5 trichlorophenoxyacetic acid (2",
"Synonmys":"2,4,D\/2,4,5,T\nAgent Orange",
"NCI_code":"NCI Thesaurus Code:C33901"
},
{
"Name":"Linolenic acid",
"Definition":"Definition: An essential fatty acid belonging to the omega-3 fatty acids group. It is highly concentrated in certain plant oils and has been reported to inhibit the synthesis of prostaglandin resultin",
"Synonmys":".alpha.-Linolenic acid\nALA\nAlpha-Linolenic Acid\nFatty Acid cis, cis, cis 18:3 n-3\nLINOLENIC ACID\nLinolenic Acid",
"NCI_code":"NCI Thesaurus Code:C997 "
},
{
"Name":"Vitamin B",
"Definition":"A class of nutrients that are in the water-soluble B-vitamin family. B vitamins include thiamine, riboflavin, niacin (nicotinic acid), niacinamide (nicotinamide), the vitamin B6 group (including pyrid",
"Synonmys":"B Vitamin\nB Vitamin Family\nB Vitamins",
"NCI_code":"NCI Thesaurus Code:C45812"
},
{
"Name":"Beta-Carotene",
"Definition":"A naturally-occurring retinol (vitamin A) precursor obtained from certain fruits and vegetables with potential antineoplastic and chemopreventive activities. As an anti-oxidant, beta carotene inhibits",
"Synonmys":"BETA.-CAROTENE\nbeta.-Carotene\n3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene\nbeta carotene\nBeta Carotene\nbeta-Carotene\nBeta-carotene\nBeta-Caroten",
"NCI_code":"NCI Thesaurus Code:C1016"
},
{
"Name":"Vitamin C",
"Definition":"NCI-GLOSS Definition: A nutrient that the body needs in small amounts to function and stay healthy. Vitamin C helps fight infections, heal wounds, and keep tissues healthy. It is an antioxidant that h",
"Synonmys":"vitamin C\nVitamin C",
"NCI_code":"NCI Thesaurus Code:C68507"
},
{
"Name":"Cholesterol",
"Definition":"An animal sterol found in the body tissues (and blood plasma) of vertebrates. It can be found in large concentrations within the liver, spinal cord, and brain. Cholesterol is an important component of",
"Synonmys":"(-)-Cholesterol\n(3beta)-Cholest-5-en-3-ol\n5-cholesten-3B-ol\nCholesterol\nCHOLESTEROL\ncholesterol",
"NCI_code":"NCI Thesaurus Code:C369"
},
{
"Name":"Vitamin D",
"Definition":"Definition: A family of lipo-soluble steroids important to the absorption, metabolism, and function of calcium and phosphorus and the growth and development of bone and tooth enamel. Found naturally i",
"Synonmys":"3-[2-[7a-methyl-1-(1,4,5-trimethylhex-2-enyl)-1,2,3,3a,5,6,7,7a-octahydroinden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol\nD Vitamin\nvitamin D\nVitamin D\nVitamin D Compound\nVitamin-D",
"NCI_code":"NCI Thesaurus Code:C941"
},
{
"Name":"Vitamin E",
"Definition":"Definition: A natural fat-soluble antioxidant with potential chemopreventive activity. Also known as tocopherol, vitamin E ameliorates free-radical damage to biological membranes, protecting polyunsat",
"Synonmys":"2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol\n3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol\n5,7,8-Trimethyltocol\nE Vitamin\nvitamin E\nVitamin E\nVitami",
"NCI_code":"NCI Thesaurus Code:C942"
},
{
"Name":"Folate",
"Definition":"Definition: A cofactor for 1-carbon transfer involved with DNA synthesis.\nCRCH Definition: Class of water-soluble vitamins that are coenzymes in single-carbon transfers in the metabolism of nucleic an",
"Synonmys":"2-[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioic acid;\nFolate\nfolate\nVitamin B-11",
"NCI_code":"NCI Thesaurus Code:C1444"
},
{
"Name":"Vitamin K",
"Definition":"The term \"vitamin K\" refers to a group of chemically similar fat-soluble compounds called naphthoquinones: vitamin K1 (phytonadione) is found in plants and is the primary source of vitamin K for human",
"Synonmys":"2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione\nVitamin K\nvitamin K",
"NCI_code":"NCI Thesaurus Code:C943"
},
{
"Name":"Tomato",
"Definition":"Lycopene is a carotenoid that is present in tomatoes, processed tomato products and other fruits. It is one of the most potent antioxidants among dietary carotenoids. Dietary intake of tomatoes and to",
"Synonmys":"TOMATO\nTomato",
"NCI_code":"NCI Thesaurus Code:C72019"
},
{
"Name":"Lycopene",
"Definition":"A linear, unsaturated hydrocarbon carotenoid, the major red pigment in fruits such as tomatoes, pink grapefruit, apricots, red oranges, watermelon, rosehips, and guava. As a class, carotenoids are pig",
"Synonmys":"2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene\nall-trans-Lycopene\nLyc-O-Mato\nLycopene\nlycopene\nLYCOPENE\npsi,psi-Carotene",
"NCI_code":"NCI Thesaurus Code:C2226"
},
{
"Name":"Multivitamin",
"Definition":"A dietary supplement containing all or most of the vitamins that may not be readily available in the diet. Vitamins may be classified according to their solubility either in lipids (vitamins A, D, E, ",
"Synonmys":"Geritol\nMultivitamin\nVitamin Supplements (NOS)",
"NCI_code":"NCI Thesaurus Code:C1654"
},
{
"Name":"Mineral",
"Definition":"A solid, homogeneous, inorganic substance occurring in nature and having a definite chemical composition.\nNCI-GLOSS Definition: In medicine, a mineral is a nutrient that is needed in small amounts to ",
"Synonmys":"mineral\nMineral\nMinerals",
"NCI_code":"NCI Thesaurus Code:C656"
},
{
"Name":"Vitamin",
"Definition":"A group of organic food substances found in animals and plants in small quantities. They must be supplied in diet or dietary supplement and are essential for normal metabolism.\nCRCH Definition: A clas",
"Synonmys":"vitamin\nVitamin\nVitamins",
"NCI_code":"NCI Thesaurus Code:C944"
},
{
"Name":"Drug and operation",
"Definition":"A drug product that contains one or more active and\/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredien",
"Synonmys":"Drug\nDrug Product\ndrug product\nMedication\nmedication\nMedicine",
"NCI_code":"NCI Thesaurus Code:C459 "
},
{
"Name":"Anticoagulant Agent",
"Definition":"Any agent capable of preventing blood clot formation.\nNCI-GLOSS Definition: A substance that is used to prevent and treat blood clots in blood vessels and the heart",
"Synonmys":"anticoagulant\nAnticoagulant Agent\nAnticoagulant Drugs\nAnticoagulants\nAnticoagulation Therapy\nblood thinner",
"NCI_code":"NCI Thesaurus Code:C263"
},
{
"Name":"Anti-diabetic Agent",
"Definition":"Any substance used to reduce hyperglycemia or treat disorders associated with diabetes. Based on their mechanism of action, this class of agents can be classified to the following groups: directly act",
"Synonmys":"Anti-diabetic Agent\nAnti-diabetics\nAntidiabetic Agent",
"NCI_code":"NCI Thesaurus Code:C29711"
},
{
"Name":"Antihypertensive Agent",
"Definition":"Any substance used in the treatment of acute or chronic hypertension regardless of pharmacological mechanism. Antihypertensive agents include diuretics, alpha-adrenergic and beta-adrenergic antagonist",
"Synonmys":"Antihypertensive Agent\nAntihypertensive Drugs\nAntihypertensives\nHypotensive Agents\nHypotensive Drugs\nHypotensives",
"NCI_code":"NCI Thesaurus Code:C270"
},
{
"Name":"Anti-inflammatory",
"Definition":"NCI-GLOSS Definition: Having to do with reducing inflammation.",
"Synonmys":"Anti-inflammatory\nanti-inflammatory",
"NCI_code":"NCI Thesaurus Code:C28347"
},
{
"Name":"Aspirin",
"Definition":"An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acetylates serine residues in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platele",
"Synonmys":"2-(Acetyloxy)benzoic Acid\nAcetylsalicylic Acid\nAcetylsalicylic acid\nASA\nAspergum\nAspirin\naspirin\nASPIRIN\nEcotrin\nEmpirin\nEntericin\nExtren\nMeasurin",
"NCI_code":"NCI Thesaurus Code:C287"
},
{
"Name":"Cimetidine",
"Definition":"Definition: A histamine H(2)-receptor antagonist. Enhancing anti-tumor cell-mediated responses, cimetidine blocks histamine's ability to stimulate suppressor T lymphocyte activity and to inhibit natur",
"Synonmys":"Cimetidine\nCIMETIDINE\ncimetidine\nGuanidine, N''-Cyano-N-Methyl-N'-(2-(((5-Methyl-1H-Imidazol-4-yl)Methyl)Thio)Ethyl)-\nN-Cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine\n",
"NCI_code":"NCI Thesaurus Code:C374"
},
{
"Name":"Metformin",
"Definition":"Definition: An agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Metformin is associated with a very low incidence of lactic acidosis. This agent helps reduce LD",
"Synonmys":"1,1-Dimethylbiguanide\nMetformin\nmetformin\nMETFORMIN\nN,N-Dimethylimidodicarbonimidic Diamide",
"NCI_code":"NCI Thesaurus Code:C61612 "
},
{
"Name":"HMG-CoA Reductase Inhibitor",
"Definition":"Any substance that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis. Inhibition of HMG-CoA reductase acts to lower plasma cholesterol and lipoprotein levels.\nNCI-GLOSS Definition: Any",
"Synonmys":"HMG-CoA reductase inhibitor\nHMG-CoA Reductase Inhibitor\nHydroxymethylglutaryl CoenzymeA Reductase Inhibitors\nhydroxymethylglutaryl-coenzyme A reductase inhibitor\nstatin\nStatin",
"NCI_code":"NCI Thesaurus Code:C1655"
},
{
"Name":"Vasectomy",
"Definition":"Surgical removal of part or all of the vas deferens.\nNCI-GLOSS Definition: An operation to cut or tie off the two tubes that carry sperm out of the testicles.",
"Synonmys":"Vasectomy\nvasectomy",
"NCI_code":"NCI Thesaurus Code:C15348"
},
{
"Name":"Warfarin",
"Definition":"A synthetic anticoagulant. Warfarin inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors, which include Factors II, VII, IX and X, and the antic",
"Synonmys":"1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone\n3-(.alpha.-Acetonylbenzyl)-4-hydroxycoumarin\n3-(.alpha.-Phenyl-.beta.-acetylethyl)-4-hydroxycoumarin\n3-(Alpha-acetonylbenzyl)-4-hydroxycoumarin\n3-Alpha",
"NCI_code":"NCI Thesaurus Code:C945"
},
{
"Name":"Disease or disorder",
"Definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuri",
"Synonmys":"condition\nDisease\ndisease\nDisease or Disorder\nDisease or Disorder, Non-Neoplastic\nDiseases\nDiseases and Disorders\nDisorder\ndisorder\nDisorders\nOther Disease",
"NCI_code":"NCI Thesaurus Code:C2991"
},
{
"Name":"IgE",
"Definition":"An immunoglobulin isotype (subclass). This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine producti",
"Synonmys":"IgE\nImmunoglobulin E",
"NCI_code":"NCI Thesaurus Code:C567"
},
{
"Name":"Atopy ",
"Definition":"A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic r",
"Synonmys":"Atopic Allergy\nAtopy\n",
"NCI_code":"NCI Thesaurus Code:C41366"
},
{
"Name":"Acne",
"Definition":"Definition: An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and\/or pustules on the skin.\nNCI-GLOSS Definition: A disorder of the skin in which oil",
"Synonmys":"acne\nAcne\nAcne Vulgaris",
"NCI_code":"NCI Thesaurus Code:C27195"
},
{
"Name":"Cardiorespiratory fitness",
"Definition":"The ability of the heart and lungs to deliver blood and oxygen to the tissues during aerobic activity. It is a general measure of the relative conditioning of the heart and respiratory system.",
"Synonmys":"Cardiorespiratory Fitness",
"NCI_code":"NCI Thesaurus Code:C88164"
},
{
"Name":"Coronary artery disease",
"Definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis ",
"Synonmys":"CAD\ncoronary artery disease\nCoronary Artery Disease\nCoronary Disease\ncoronary heart disease",
"NCI_code":"NCI Thesaurus Code:C26732"
},
{
"Name":"Hyperparathyroidism",
"Definition":"Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroi",
"Synonmys":"Hyperparathyroidism\nhyperparathyroidism",
"NCI_code":"NCI Thesaurus Code:C48259"
},
{
"Name":"Diabetes mellitus",
"Definition":"Definition: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance\/desensitization.\nNCI-GLOSS Definition: A disease in w",
"Synonmys":"Diabetes\ndiabetes\nDiabetes Mellitus\ndiabetes mellitus\nDM",
"NCI_code":"NCI Thesaurus Code:C2985"
},
{
"Name":"Infections",
"Definition":"Infectious complications following prostate biopsy can range from those confined to the genitourinary tract (urinary tract infection [UTI], epididymitis, prostatitis) to sepsis.Escherichia coli is the",
"Synonmys":"Infections",
"NCI_code":"NA"
},
{
"Name":"Metabolic syndrome",
"Definition":"Definition: A combination of medical conditions that, when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pres",
"Synonmys":"Metabolic Syndrome\nmetabolic syndrome\nmetabolic syndrome X\nMetabolic Syndrome X",
"NCI_code":"NCI Thesaurus Code:C84442"
},
{
"Name":"Obesity",
"Definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).\nCTCAE Definition: A disorder characterized by having a high amount of body fat.\nNCI-GLOSS Definition: A condition marked by an a",
"Synonmys":"Obesity\nobesity",
"NCI_code":"NCI Thesaurus Code:C3283"
},
{
"Name":"Prostatic intraepithelial neoplasia",
"Definition":"A neoplastic proliferation of the epithelial cells that line the acini and the ducts of the prostate gland. The neoplastic epithelial cells are confined within the acini and the ducts and they do not ",
"Synonmys":"PIN\nPIN - Prostatic Intraepithelial Neoplasia\nProstate intraepithelial neopl.\nProstate intraepithelial neoplasia (PIN)\nprostatic intraepithelial neoplasia\nProstatic Intraepithelial Neoplasia",
"NCI_code":"NCI Thesaurus Code:C4064"
},
{
"Name":"Prostatitis",
"Definition":"An infectious or non-infectious inflammatory process affecting the prostate gland.\nNICHD Definition: An inflammatory process affecting the prostate gland.\nNCI-GLOSS Definition: Inflammation of the pro",
"Synonmys":"Prostatitis\nprostatitis",
"NCI_code":"NCI Thesaurus Code:C26866"
},
{
"Name":"The absence of voiding symptoms ",
"Definition":"There was one question on obstructive voiding symptoms: “Do you have voiding symptoms in terms of weak stream or difficulty emptying the bladder?” The answers were ranked on an ordinal scale from 1 to",
"Synonmys":"The absence of voiding symptoms ",
"NCI_code":"NA"
},
{
"Name":"Environmental and Social Factors Supplemental Qual",
"Definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the environmental and social factors domain.\nCDISC Definition: A dataset used to represent non-",
"Synonmys":"Environmental and Social Factors Supplemental Qualifiers Dataset\nSUPPER\nSupplemental Qualifiers for Environmental and Social Factors",
"NCI_code":"NCI Thesaurus Code:C147210"
},
{
"Name":"Diesel exposure",
"Definition":"A job-exposure matrix was used for assigning exposure. For the calculation of dose-years, the duration of contact with specific substances was weighted by the intensity and probability of exposure acc",
"Synonmys":"Diesel exposure",
"NCI_code":"NA"
},
{
"Name":"Education",
"Definition":"The activities of educating or instructing or teaching; activities that impart knowledge or skill.",
"Synonmys":"Education",
"NCI_code":"NCI Thesaurus Code:C16529"
},
{
"Name":"Farming, Fishing, and Forestry Occupations",
"Definition":"A class of professional or vocational positions of employment that involve farming, fishing or forestry.",
"Synonmys":"Farming, Fishing, and Forestry\nFarming, Fishing, and Forestry Occupations",
"NCI_code":"NCI Thesaurus Code:C97632"
},
{
"Name":"Long working hours",
"Definition":"Working longer than the maximum recommended hours is associated with an increased risk of cardiovascular disease, but the relationship of excess working hours with incident cancer is unclear.\nWorking ",
"Synonmys":"Long working hours",
"NCI_code":"NA"
},
{
"Name":"Night shift worker",
"Definition":"A group of workers who work a shift during the night in an industry or occupation where a day shift or a back shift is also worked",
"Synonmys":"Night shift worker (finding)",
"NCI_code":"BioPortal cui:C0555008"
},
{
"Name":"Occupation",
"Definition":"The principal activity that a person does to earn money.\nCDISC Definition: A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient ca",
"Synonmys":"EMPJOB\nEmployee Job\nJob\nOccupation\nOCCUPATION",
"NCI_code":"NCI Thesaurus Code:C25193"
},
{
"Name":"Work environment",
"Definition":"The term work environment is used to describe the surrounding conditions in which an employee operates. The work environment can be composed of physical conditions, such as office temperature, or equi",
"Synonmys":"Workplace\nWork environment (environment)\nWork location",
"NCI_code":"BioPortal cui:C0162579"
},
{
"Name":"Stress",
"Definition":"A disorder characterized by two or more episodes in which the patient's mood and activity levels are significantly disturbed, this disturbance consisting on some occasions of an elevation of mood and ",
"Synonmys":"Psychological stress\nState of stress\nStress (finding)",
"NCI_code":"BioPortal cui:C0038435"
},
{
"Name":"Foods",
"Definition":"Any nutritious substance that people or animals eat or drink or that plants absorb in order to maintain life and growth.",
"Synonmys":"Foods",
"NCI_code":"NA"
},
{
"Name":"Sulforaphane",
"Definition":"A naturally-occurring phytochemical belonging to the class of isothiocyanates. As the aglycone metabolite of glucosinolate glucoraphanin (sulforaphane glucosinolate), sulforaphane acts as an antioxida",
"Synonmys":"(+\/-)-Sulforaphane\n1-Isothiocyanato-4-(methylsulfinyl)butane\n1-isothiocyanato-4-methylsulfinyl-butane\nSulfaforaphane\nSulforafan\nSulforaphane\nSulphoraphane",
"NCI_code":"NCI Thesaurus Code: C1424"
},
{
"Name":"Broccoli",
"Definition":"Broccoli is an edible green plant in the cabbage family whose large flowering head is eaten as a vegetable. The word broccoli comes from the Italian plural of broccolo, which means \"the flowering cres",
"Synonmys":"BROCCOLI\nBroccoli",
"NCI_code":"NCI Thesaurus Code:C71997"
},
{
"Name":"Dietary Inflammatory Index",
"Definition":"The centered percentile score for each food parameter for each individual was then multiplied by the respective food parameter effect score (inflammatory potential for each food parameter), which was ",
"Synonmys":"Dietary Inflammatory Index",
"NCI_code":"NA"
},
{
"Name":"Carbohydrate",
"Definition":"Definition: A class of hydrocarbons with an empirical formula of Cm(H20)n (where m and n may be equal) and includes monomers, polymers and derivatives of aldoses, ketoses, saccharides, and alditols.\nN",
"Synonmys":"Carbohydrate\ncarbohydrate\nCarbohydrates",
"NCI_code":"NCI Thesaurus Code:C344"
},
{
"Name":"Glucosinolate",
"Definition":"A class of organic compounds that are derived from a glucose that has been modified by an amino acid. These compounds are anionic sulfur-containing glucosides, produced as secondary metabolites by pla",
"Synonmys":"Glucosinolate;\nGlucosinolates",
"NCI_code":"NCI Thesaurus Code:C112047 "
},
{
"Name":"Heterocyclic Amines",
"Definition":"Exhibiting a cyclic structure containing at least one amino (NH2) group, some Heterocyclic Amines are carcinogenic chemicals formed from cooking meat such as beef, pork, fowl, and fish when amino acid",
"Synonmys":"HAA;\nHCA;\nheterocyclic amine;\nHeterocyclic Amines;\nHeterocyclic Aromatic Amine;\nHeterocyclic Aromatic Amines",
"NCI_code":"NCI Thesaurus Code:C1926"
},
{
"Name":"Dietary fat intake",
"Definition":"ost-diagnostic fat intake was assessed using a validated food frequency questionnaire (FFQ) administered between 1997 and 2001 (11). Men were asked to report their usual intake of 61 foods and beverag",
"Synonmys":"Dietary fat intake (observable entity)",
"NCI_code":"BioPortal cui:C0425440"
},
{
"Name":"Fatty Acid",
"Definition":"Monobasic, aliphatic acids with varying chain lengths between 6 and 30. Fatty acids are a major constituent in all fats and can be either saturated, monounsaturated, or polyunsaturated. Saturated and ",
"Synonmys":"Fatty Acid\nfatty acid\nFatty Acids",
"NCI_code":"NCI Thesaurus Code:C492"
},
{
"Name":"Whole fat",
"Definition":"Cronobacter (in TSB), inoculated skim milk (0% fat), low-fat milk (1% and 2% fat) and whole-fat milk (3.5% fat) were treated with 0.0, 0.1, 0.5, 0.75, 1.0, 2.0, 3.0, 4.0, 5.0 and 6.0 kGy X-ray doses",
"Synonmys":"Whole fat",
"NCI_code":"NA"
},
{
"Name":"Fiber",
"Definition":"FDA Definition: An elongated, tapering, generally thick-walled sclerenchyma cell of vascular plants; its walls may or may not be lignified",
"Synonmys":"Fiber;\nFibra",
"NCI_code":"NCI Thesaurus Code: C1502"
},
{
"Name":"Fish",
"Definition":"A grouping of jawed and jawless vertebrate animals usually having fins and a covering of scales or plates, breathing by means of gills, and living almost entirely in the water.\nCDISC Definition: Any j",
"Synonmys":"FISH;\nfish;\nFish (NOS)\n",
"NCI_code":"NCI Thesaurus Code:C14207 "
},
{
"Name":"Meat",
"Definition":"Definition: The flesh of animals used as food.",
"Synonmys":"Meat",
"NCI_code":"NCI Thesaurus Code:C126482"
},
{
"Name":"Cow Milk",
"Definition":"Definition: A body substance containing proteins, fats, lactose, and various vitamins and minerals produced by the mammary glands of mature female bovines.",
"Synonmys":"COW MILK\nCow Milk\nMilk",
"NCI_code":"NCI Thesaurus Code:C66153 "
},
{
"Name":"Pizza",
"Definition":"Pizza is a traditional Italian dish consisting of a yeasted flatbread typically topped with tomato sauce and cheese and baked in an oven. It can also be topped with additional vegetables, meats, and c",
"Synonmys":"Pizza (substance)",
"NCI_code":"BioPortal cui:C0453577"
},
{
"Name":"Plant",
"Definition":" Any living organism that typically synthesizes its food from inorganic substances, possesses cellulose cell walls, responds slowly and often permanently to a stimulus, lacks specialized sense organs ",
"Synonmys":"plant;\nplants;\nPlants,general;\nviridiplantae",
"NCI_code":"NCI Thesaurus Code:C14258"
},
{
"Name":"Preserved foods",
"Definition":"Preserved foods have been found in some studies to be associated with increased cancer risks. The total amount of preserved food consumed was positively associated with cancer risk, the adjusted odds ",
"Synonmys":"Preserved foods",
"NCI_code":"NA"
},
{
"Name":"Pomegranate",
"Definition":"NCI-GLOSS Definition: A subtropical shrub or tree. Juice from the fruit may contain substances that decrease or slow the rise of prostate-specific antigen (PSA) levels. It is being studied for its abi",
"Synonmys":"POMEGRANATE\nPomegranate\npomegranate",
"NCI_code":"NCI Thesaurus Code:C73929"
},
{
"Name":"Rice consumption",
"Definition":"Information on rice consumption was first assessed in 1980 in NHS participants using a validated semi-quantitative food frequency questionnaire (SFFQ), and repeated in 1984, 1986, and every 4 years th",
"Synonmys":"Starch, Rice\nSTARCH, RICE",
"NCI_code":"NCI Thesaurus Code:C80780"
},
{
"Name":"Soybean",
"Definition":"NCI-GLOSS Definition: A product from a plant of Asian origin that produces beans used in many food products. Soybean contains isoflavones (estrogen-like substances) that are being studied for the prev",
"Synonmys":"Glycine max;\nsoy;\nsoya;\nSoybean;\nSOYBEAN;\nsoybean",
"NCI_code":"NCI Thesaurus Code:C72010"
},
{
"Name":"Isoflavone",
"Definition":"Definition: A class of polyphenolic compounds derived from the Fabaceae family with potential phytoestrogenic, cholesterol-reducing, chemotherapeutic and antioxidant activity. In isoflavones the pheny",
"Synonmys":"3-phenylchromone\nIsoflavone\nISOFLAVONE\nisoflavone\nIsoflavones\nSoy Isoflavones",
"NCI_code":"NCI Thesaurus Code:C599"
},
{
"Name":"Fruit",
"Definition":"A structure consisting of the fertilized and mature ovules (\"seeds\") and the ovary wall, which may be fleshy (as in the apple) or dry and hard (as in a maple fruit.",
"Synonmys":"Fructus\/Fruit\nFRUIT, UNSPECIFIED",
"NCI_code":"NCI Thesaurus Code:C71972"
},
{
"Name":"Cruciferous Vegetable",
"Definition":"Definition: Edible plants from the family Brassicaceae (also called Cruciferae).\nNCI-GLOSS Definition: A member of the family of vegetables that includes broccoli, Brussels sprouts, cabbage, cauliflow",
"Synonmys":"cruciferous vegetable\nCruciferous Vegetable\nCruciform Vegetables",
"NCI_code":"NCI Thesaurus Code:C1747"
},
{
"Name":"Physiological and biochemical",
"Definition":"The scientific study of an organism's vital functions, including growth and development, the absorption and processing of nutrients, the synthesis and distribution of proteins and other organic molecu",
"Synonmys":"Physiological & biochemical",
"NCI_code":"NA"
},
{
"Name":"Androgen receptor",
"Definition":"Androgen receptor (919 aa, ~99 kDa) is encoded by the human AR gene. This protein plays a role in the modulation of steroid-dependent gene transcription.",
"Synonmys":"Androgen Receptor;AR;DHTR;\nDihydrotestosterone Receptor;\nNR3C4;Nuclear Receptor Subfamily 3 Group C Member 4",
"NCI_code":"NCI Thesaurus Code:C17063"
},
{
"Name":"Birth",
"Definition":"The event of being born.\nGAIA Definition: The birth of an offspring, which breathes or shows evidence of life, or is born without signs of life at an estimated gestation of 24 weeks or more (as define",
"Synonmys":"Birth\nBorn\nDelivery",
"NCI_code":"NCI Thesaurus Code:C25155"
},
{
"Name":"Birth size",
"Definition":"Compared with BWs between 3000 and 3500 g (reference), the fully adjusted odds ratios (OR, 95% CI) were 0.55 (0.33-0.91) for <3000 g, 0.86 (0.61-1.22) for 3500-4000 g and 0.98 (0.64-1.50) for >4000 g.",
"Synonmys":"Birth size",
"NCI_code":"NA"
},
{
"Name":"Birth height",
"Definition":"Birth weight is the body weight of a baby at its birth. The average birth weight in babies of European heritage is 3.5 kilograms (7.7 lb), though the range of normal is between 2.5 kilograms (5.5 lb) ",
"Synonmys":"Birth height",
"NCI_code":"NA"
},
{
"Name":"Body Mass Index",
"Definition":"A general indicator of the body fat an individual is carrying based upon the ratio of weight to height.\nNCI-GLOSS Definition: A measure that relates body weight to height. BMI is sometimes used to mea",
"Synonmys":"BMI;\nBody Mass Index;\nbody mass index;\nQuetelet Index;",
"NCI_code":"NCI Thesaurus Code:C16358"
},
{
"Name":"Body weight",
"Definition":"The weight of a subject.",
"Synonmys":"Body Weight;BW",
"NCI_code":"NCI Thesaurus Code:C81328"
},
{
"Name":"Brugada-like electrocardiogram",
"Definition":"The Brugada electrocardiogram pattern is characterized by coved-type ST-elevation (>2 mm) in the right precordial leads. We report the case of a 62-year-old man, with bipolar disorder, admitted to the",
"Synonmys":"ECG\nEKG\nElectrocardiogram\nelectrocardiogram\nElectrocardiography",
"NCI_code":"NCI Thesaurus Code:C38053"
},
{
"Name":"Alopecia",
"Definition":"A hypotrichosis that is characterized by a loss of hair from the head or body. (\nhttp:\/\/en.wikipedia.org\/wiki\/Alopecia, http:\/\/www.omim.org\/entry\/109200?search=109200&highlight=109200)",
"Synonmys":"Hair loss disorder\nBald\nAlopecia (disorder)\nBaldness",
"NCI_code":"BioPortal cui:C0002170"
},
{
"Name":"Cytokine Expression Profile",
"Definition":"The identification and quantitation of all of the cytokines expressed in a biological sample.",
"Synonmys":"Cytokine Expression Profile;\nCytokine Profile",
"NCI_code":"NCI Thesaurus Code:C129886"
},
{
"Name":"Deficient nucleotide excision repair capacity",
"Definition":"NA",
"Synonmys":"Deficient nucleotide excision repair capacity",
"NCI_code":"NA"
},
{
"Name":"Endocrine",
"Definition":"Definition: Collective designation for those tissues capable of secreting hormones.\nNCI-GLOSS Definition: Refers to tissue that makes and releases hormones that travel in the bloodstream and control t",
"Synonmys":"Endocrine;\nendocrine",
"NCI_code":"NCI Thesaurus Code:C41064"
},
{
"Name":"Impotence",
"Definition":"Definition: Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.\nNCI-GLOSS Definition: An inability to have an erection of the penis adequate for sexual inte",
"Synonmys":"Erectile Dysfunction\nErectile dysfunction\nerectile dysfunction\nImpotence\/impotence\nimpotent\/Impotent",
"NCI_code":"NCI Thesaurus Code:C3133 "
},
{
"Name":"Height",
"Definition":"The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension.\nDICOM Definition: Vertical measurement value.\nCDISC Definition: The vertical measuremen",
"Synonmys":"Height\nHEIGHT",
"NCI_code":"NCI Thesaurus Code:C25347"
},
{
"Name":"Hormonal",
"Definition":"Relating to hormones.",
"Synonmys":"Hormonal",
"NCI_code":"NCI Thesaurus Code:C25528"
},
{
"Name":"IGF1 Gene",
"Definition":"This gene is involved in cellular communication, growth and proliferation. It also plays a role in the regulation of muscular and skeletal development.",
"Synonmys":"IGF1;IGF1 Gene;\nInsulin-Like Growth Factor 1 (Somatomedin C) Gene",
"NCI_code":"NCI Thesaurus Code:C24485 "
},
{
"Name":"Infertility",
"Definition":"Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Cau",
"Synonmys":"Fertility Disorders;\ninfertile\nInfertile\nInfertility\ninfertility\nsterile\nSterile\nSterility",
"NCI_code":"NCI Thesaurus Code:C3836"
},
{
"Name":"Lactose Intolerance",
"Definition":"Inability to fully digest and absorb lactose due to limited or no lactase activity in the small intestine. Congenital intolerance is inherited following an autosomal recessive pattern but is rare. It ",
"Synonmys":"Lactose Intolerance\nlactose Intolerance",
"NCI_code":"NCI Thesaurus Code:C3154"
},
{
"Name":"Leptin",
"Definition":"Leptin (167 aa, ~16 kDa) is encoded by the human LEP gene. This protein is secreted by adipocytes and plays a role in the regulation of both appetite and body fat stores.",
"Synonmys":"Leptin;\nObese Protein\nObesity Factor",
"NCI_code":"NCI Thesaurus Code:C46081"
},
{
"Name":"Late Fetal Death",
"Definition":"Death of a fetus at 16 weeks, 0 days to 19 weeks, 6 days of gestation.",
"Synonmys":"Late Fetal Death",
"NCI_code":"NCI Thesaurus Code:C112863"
},
{
"Name":"Neutering",
"Definition":"Neutering, from the Latin neuter, is the removal of an animal's reproductive organ, either all of it or a considerably large part. \"Neutering\" is often used incorrectly to refer only to male animals, ",
"Synonmys":"Neutering",
"NCI_code":"NA"
},
{
"Name":"Oxidative Stress",
"Definition":"A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid",
"Synonmys":"Oxidative Stress;\noxidative Stress",
"NCI_code":"NCI Thesaurus Code:C17741"
},
{
"Name":"Phytooestrogen",
"Definition":"Hytoestrogens are plant‐derived dietary compounds, found in a wide variety of foods, especially in soy. They represent a diverse group of naturally occurring chemicals with structural similarity to 17",
"Synonmys":"Phytooestrogen",
"NCI_code":"NA"
},
{
"Name":"Plasma enterolactone",
"Definition":"Enterolactone (ENL) is an enterolignan, which in humans is formed in the gut from various dietary lignans through the action of colonic bacteria, and is later detectable in the circulation， Lignans co",
"Synonmys":"Plasma enterolactone",
"NCI_code":"NA"
},
{
"Name":"Steroid Hormone Receptor",
"Definition":"Definition: Steroid hormone receptors are proteins found in either the cytoplasm or nucleus of eukaryotic cells which bind to and regulate the transcription of DNA under the regulation of steroid horm",
"Synonmys":"Estrogen Receptor-Like Subfamily\nNuclear Receptor Subfamily 3\nSteroid Hormone Receptor\nSteroid Hormones, Receptor\nSteroid Hormones, Receptors",
"NCI_code":"NCI Thesaurus Code:C18108"
},
{
"Name":"Testosterone",
"Definition":"NCI-GLOSS Definition: A hormone made mainly in the testes (part of the male reproductive system). It is needed to develop and maintain male sex characteristics, such as facial hair, deep voice, and mu",
"Synonmys":"(17Beta)-17-hydroxyandrost-4-en-3-one;\nDelta4-androsten-17beta-ol-3-one\nTestosterone;testosterone\nTrans-Testosterone",
"NCI_code":"NCI Thesaurus Code:C2299"
},
{
"Name":"Urinary estrogen metabolites",
"Definition":"The two main pathways for metabolism of estrogens are 16α-hydroxylation and 2-hydroxylation. The major estrogen metabolites excreted in urine are the parent estrone (E1) and 17β-estradiol (E2), 2-hydr",
"Synonmys":"Urinary estrogen metabolites",
"NCI_code":"NA"
},
{
"Name":"Waist-Hip Ratio",
"Definition":"The ratio of the abdominal circumference at the navel to maximum hip and buttocks circumference; looks at the proportion of fat stored on the body around the waist and hip. Carrying extra weight aroun",
"Synonmys":"Waist to Hip Ratio\nWaist-Hip Ratio\nWAISTHIP",
"NCI_code":"NCI Thesaurus Code:C17651"
},
{
"Name":"Nutrition, Food Additives",
"Definition":"Role of food additives in cancer causation or prevention and in general health.",
"Synonmys":"Nutrition, Food Additives",
"NCI_code":"NCI Thesaurus Code:C15235"
},
{
"Name":"Beta-Carotene",
"Definition":"A naturally-occurring retinol (vitamin A) precursor obtained from certain fruits and vegetables with potential antineoplastic and chemopreventive activities. As an anti-oxidant, beta carotene inhibits",
"Synonmys":".BETA.-CAROTENE\n.beta.-Carotene\n3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene\nbeta carotene\nBeta Carotene\nbeta-Carotene\nBeta-carotene\nBeta-Carot",
"NCI_code":"NCI Thesaurus Code:C1016"
},
{
"Name":"Alpha-Tocopherol",
"Definition":"The orally bioavailable alpha form of the naturally-occurring fat-soluble vitamin E, with potent antioxidant and cytoprotective activities. Upon administration, alpha-tocopherol neutralizes free radic",
"Synonmys":"ALPHA.-TOCOPHEROL\n2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol\n3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol\nAlpha-tocopherol\nAlpha-Tocopherol",
"NCI_code":"NCI Thesaurus Code:C74960"
},
{
"Name":"Choline",
"Definition":"CRCH Definition: Water-soluble vitamin that is a precursor for acetylcholine, phospholipids, and the methyl donor betaine. (DRI)\nNCI-GLOSS Definition: A nutrient in the vitamin B complex that the body",
"Synonmys":"(2-Hydroxyethyl)trimethylammonium\n2-hydroxyethyl-trimethyl-ammonium\nCHOLINE\ncholine\nCholine\nVitamin J",
"NCI_code":"NCI Thesaurus Code:C61674"
},
{
"Name":"Unclear type",
"Definition":"NA",
"Synonmys":"Unclear type",
"NCI_code":"NA"
},
{
"Name":"C Peptide",
"Definition":"C peptide (31 aa, ~3 kDa) is encoded by the human INS gene. This protein is involved in both signal transduction and the modulation of blood flow.\nNCI-GLOSS Definition: A substance made by the pancrea",
"Synonmys":"C Peptide\nC-peptide\nC-Peptide\nconnecting peptide\nHuman Proinsulin C-Peptide\nProinsulin C-Peptide",
"NCI_code":"NA"
},
{
"Name":"Diagnostic aspects of prostate cancer",
"Definition":"Characteristic or indicative of a condition.",
"Synonmys":"DIAG\nDiagnostic",
"NCI_code":"NCI Thesaurus Code:  C25482"
},
{
"Name":"Prostate symptom",
"Definition":"Identifying prostate problems early is a way to reduce future prostate problems; symptoms include frequent urination, blood in urine, painful urination, dribbling urination, inability to urinate, pain",
"Synonmys":"Prostate symptom",
"NCI_code":"NA"
},
{
"Name":"Lower urinary tract symptoms",
"Definition":"Lower urinary tract symptoms (LUTS) include voiding or obstructive symptoms such as hesitancy, poor and\/or intermittent stream, straining, prolonged micturition, feeling of incomplete bladder emptying",
"Synonmys":"Lower urinary tract symptoms (LUTS)",
"NCI_code":"BioPortal cui:C0574785"
},
{
"Name":"Storage symptoms",
"Definition":"Storage symptoms may be due to an overactive bladder (OAB). OAB is when there is a feeling of urgency to urinate, usually with frequency and nocturia can happen with or without urge incontinence.",
"Synonmys":"Storage symptoms",
"NCI_code":"NA"
},
{
"Name":"Urinary Frequency",
"Definition":"Urination at short intervals; it may result from increased urine formation, decreased bladder capacity, or lower urinary tract irritation.",
"Synonmys":"Frequency, Urinary\nUrinary Frequency\nUrinary frequency",
"NCI_code":"NCI Thesaurus Code:C26906"
},
{
"Name":"Urinary Urgency",
"Definition":"An acute and compelling urge to urinate.",
"Synonmys":"Micturation Urgency\nUrinary Urgency\nUrinary urgency",
"NCI_code":"NCI Thesaurus Code:C50792 "
},
{
"Name":"Nocturia",
"Definition":"Frequent episodes of urination during the night.",
"Synonmys":"Nocturia",
"NCI_code":"NCI Thesaurus Code:C82673"
},
{
"Name":"Voiding symptoms",
"Definition":"Voiding symptoms are usually due to a blockage at the outlet of base of the bladder, making it more difficult to pass urine. The blockage may be caused by an enlarged prostate gland or scarring of the",
"Synonmys":"Voiding dysfunction",
"NCI_code":"BioPortal cui:C4067975"
},
{
"Name":"Urinary hesitancy",
"Definition":"Difficulty in initiating urination.",
"Synonmys":"Urinary Hesitancy",
"NCI_code":"NCI Thesaurus Code:C123246"
},
{
"Name":"Micturition arduous",
"Definition":"The discharge of urine from the bladder; urine from the kidneys is passed in spurts every few seconds along the ureters to the bladder, where it collects and later is passed to the outside via the ure",
"Synonmys":"Micturition arduous",
"NCI_code":"NA"
},
{
"Name":"EPIC-CP - Weak Urine Stream or Incomplete Bladder ",
"Definition":"Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) How big a problem, if any, has each of the following been for you? Weak urine stream\/incomplete bladder emptying.",
"Synonmys":"EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying\nEPIC2-Problem Weak Stream\/Incompl Empty\nEPIC205B",
"NCI_code":"NCI Thesaurus Code:C127404"
},
{
"Name":"Splitting of urinary stream",
"Definition":"The technical name for a urine stream that splits is Split Stream Urination. Split stream urination is a condition that is very common in males than it is in females. It is characterized by urine spli",
"Synonmys":"Forked stream",
"NCI_code":"BioPortal cui:C0232855"
},
{
"Name":"Intermittency",
"Definition":"Stopping and starting at intervals.",
"Synonmys":"Intermittency",
"NCI_code":"NA"
},
{
"Name":"Postvoiding symptoms",
"Definition":"NA",
"Synonmys":"Postvoiding symptoms",
"NCI_code":"NA"
},
{
"Name":"EPIC-CP - Weak Urine Stream or Incomplete Bladder ",
"Definition":"Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) How big a problem, if any, has each of the following been for you? Weak urine stream\/incomplete bladder emptying.",
"Synonmys":"EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying\nEPIC2-Problem Weak Stream\/Incompl Empty\nEPIC205B",
"NCI_code":"NCI Thesaurus Code:C127404"
},
{
"Name":"Dribbling urine",
"Definition":"NA",
"Synonmys":"Dribbling;urine",
"NCI_code":"BioPortal cui:C0149671"
},
{
"Name":"Bone Pain",
"Definition":"Painful sensation in the bones.",
"Synonmys":"Bone pain\nBone Pain\nBone pain (diffuse not joint pain or arthritis)",
"NCI_code":"NCI Thesaurus Code:C38644 "
},
{
"Name":"Hematuria",
"Definition":"Blood in the urine.",
"Synonmys":"Hematuria",
"NCI_code":"NCI Thesaurus Code:C3090 "
},
{
"Name":"Long term complication of medication",
"Definition":"NA",
"Synonmys":"long-term complications of treatment",
"NCI_code":"NA"
},
{
"Name":"Other Symptoms",
"Definition":"A question about whether an individual has or had other symptoms.",
"Synonmys":"Have Other Symptoms\nHave you experienced other symptoms",
"NCI_code":"NCI Thesaurus Code:C105783"
},
{
"Name":"Clinical Diagnosis",
"Definition":"A diagnosis made from a study of the signs and symptoms of a disease.",
"Synonmys":"Clinical Diagnosis",
"NCI_code":"NCI Thesaurus Code:C15607"
},
{
"Name":"Physical Examination",
"Definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or",
"Synonmys":"Assessment\nassessment\nPhysical\nPhysical Assessment\nPhysical Exam\nPHYSICAL EXAM\nPhysical Examination\nPHYSICAL EXAMINATION\nphysical examination",
"NCI_code":"NCI Thesaurus Code:C20989"
},
{
"Name":"Height",
"Definition":"The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension.",
"Synonmys":"Height",
"NCI_code":"NCI Thesaurus Code:C25347"
},
{
"Name":"Body Weight",
"Definition":"The weight of a subject.",
"Synonmys":"Body Weight\nBW",
"NCI_code":"NCI Thesaurus Code:C81328"
},
{
"Name":"Body Mass Index",
"Definition":"A general indicator of the body fat an individual is carrying based upon the ratio of weight to height.",
"Synonmys":"BMI\nBody Mass Index\nbody mass index\nQuetelet Index",
"NCI_code":"NCI Thesaurus Code:C16358"
},
{
"Name":"Blood Pressure",
"Definition":"The pressure of the circulating blood against the walls of the blood vessels.",
"Synonmys":"Blood Pressure\nBP",
"NCI_code":"NCI Thesaurus Code:C54706 "
},
{
"Name":"Systolic Blood Pressure",
"Definition":"The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.",
"Synonmys":"SYSBP\nSystolic Blood Pressure\nSystolic Pressure",
"NCI_code":"NCI Thesaurus Code:C25298"
},
{
"Name":"Diastolic Blood Pressure",
"Definition":"The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.",
"Synonmys":"DIABP\nDiastolic Blood Pressure\nDiastolic Pressure",
"NCI_code":"NCI Thesaurus Code:C25299"
},
{
"Name":"Digital Rectal Examination",
"Definition":"A physical examination in which the qualified health care worker inserts a lubricated, gloved finger of one hand into the RECTUM and may use the other hand to press on the lower ABDOMEN or pelvic area",
"Synonmys":"Digital Rectal Examinations",
"NCI_code":"BioPortal cui:C1384593"
},
{
"Name":"Estimated volume",
"Definition":"NA",
"Synonmys":"Estimated volume",
"NCI_code":"NA"
},
{
"Name":"Hardness",
"Definition":"The determination of the breaking point and structural integrity of a material.",
"Synonmys":"Hardness",
"NCI_code":"NCI Thesaurus Code:C134264"
},
{
"Name":"Prostate mobility",
"Definition":"NA",
"Synonmys":"Prostate mobility",
"NCI_code":"NA"
},
{
"Name":"Tenderness",
"Definition":"Discomfort elicited through touch or pressure.",
"Synonmys":"Tenderness",
"NCI_code":"NCI Thesaurus Code:C75540"
},
{
"Name":"Texture",
"Definition":"A measure of the variation of the intensity of a surface, quantifying properties such as smoothness, coarseness, regularity, and resiliency. The term is often used as a descriptor for the structure or",
"Synonmys":"Texture",
"NCI_code":"NCI Thesaurus Code:C41144"
},
{
"Name":"Lab test",
"Definition":"A procedure, usually conducted in a laboratory, that is intended to detect, identify, or quantify one or more significant substances, evaluate organ functions, or establish the nature of a condition o",
"Synonmys":"Lab test",
"NCI_code":"BioPortal cui:C0022885"
},
{
"Name":"Prostate-Specific Antigen",
"Definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.",
"Synonmys":"Antigen, Prostate-Specific\nEC 3.4.21.77\nGamma-Seminoprotein\nKallikrein-3\nKLK3\nP-30 Antigen\nProstate Specific Antigen\nProstate Specific Antigen Preproprotein\nProstate-Specific Antigen\nprostate-specific",
"NCI_code":"NCI Thesaurus Code:C17525"
},
{
"Name":"Free Prostate Specific Antigen Measurement",
"Definition":"The determination of the amount of free prostate specific antigen in a biological sample.",
"Synonmys":"Free Prostate Specific Antigen Measurement\nProstate Specific Antigen, Free\nPSAF",
"NCI_code":"NCI Thesaurus Code:C132383"
},
{
"Name":"Prostate Specific Antigen Density",
"Definition":"The ratio of serum prostate specific antigen to prostate volume.",
"Synonmys":"Prostate Specific Antigen Density\nPSA Density",
"NCI_code":"NCI Thesaurus Code:C143161"
},
{
"Name":"PSA Velocity",
"Definition":"A measurement of how fast PSA levels in the blood increase over time. A high PSA velocity may be a sign of prostate cancer and may help find fast-growing prostate cancers.\n",
"Synonmys":"Prostate Specific Antigen Velocity\nPSA Velocity\nPSA velocity",
"NCI_code":"NCI Thesaurus Code:C20119"
},
{
"Name":"Free PSA to Total PSA Ratio Measurement",
"Definition":"The determination of the ratio of free prostate specific antigen as compared to the total prostate specific antigen present in a sample. The measurement may be expressed as a ratio or percentage.",
"Synonmys":"Free PSA to Total PSA Ratio Measurement\nPSA, Free\/PSA\nPSAFPSAT",
"NCI_code":"NCI Thesaurus Code:C132384"
},
{
"Name":"4Kscore",
"Definition":"A proprietary blood test for prostate cancer screening that measures four kallikrein markers (total, free, and intact prostate-specific antigen, and human kallikrein-related peptidase 2 [hK2]).",
"Synonmys":"4K\n4Kscore\n4Kscore Blood Test",
"NCI_code":"NCI Thesaurus Code:C142184"
},
{
"Name":"Percent Free Prostate-Specific Antigen",
"Definition":"PSA circulates in the blood in two forms: free or attached to a protein molecule. With benign prostate conditions, there is more free PSA, while cancer produces more of the attached form. A more accur",
"Synonmys":"free PSA\nPercent Free Prostate-Specific Antigen",
"NCI_code":"NCI Thesaurus Code:C20042"
},
{
"Name":"Prostate Cancer Antigen 3",
"Definition":"Prostate cancer antigen 3 (~4 kb) is encoded by the human PCA3 gene. This non-coding RNA may be involved in prostate carcinoma.",
"Synonmys":"Non-Protein Coding RNA 19\nPCA3\nProstate Cancer Antigen 3",
"NCI_code":"NCI Thesaurus Code:C92559"
},
{
"Name":"(-2)pro-prostate-specific antigen, human",
"Definition":"pro-PSA is a purer marker of prostate cancer than free PSA.",
"Synonmys":"(-2)pro-prostate-specific antigen, human\n(-2)pro-PSA, human\np2PSA, human",
"NCI_code":"BioPortal cui:C3710767"
},
{
"Name":"Prostate Health Index",
"Definition":"An assay system that indirectly measures the amount of three forms of prostate-specific antigen (PSA) in a patient serum sample and then uses those values to calculate a score that estimates the patie",
"Synonmys":"PHI\nphi-index\nProstate Health Index",
"NCI_code":"NCI Thesaurus Code:C123798"
},
{
"Name":"Prostate Specific Antigen mRNA Measurement",
"Definition":"The determination of the amount of prostate specific antigen mRNA in a biological sample.",
"Synonmys":"Prostate Specific Antigen mRNA\nProstate Specific Antigen mRNA Measurement\nPSAMRNA",
"NCI_code":"NCI Thesaurus Code:C132385"
},
{
"Name":"PSA Doubling Time",
"Definition":"The number of months observed or calculated for PSA to increase two-fold.",
"Synonmys":"Prostate Specific Antigen Doubling Time\nPSA Doubling Time\nPSA-DT\nPSADT",
"NCI_code":"NCI Thesaurus Code:C143149"
},
{
"Name":"Total PSA",
"Definition":"The total amount of prostate-specific antigen (PSA) in the blood. It includes the amount of free PSA and the amount of PSA attached to other proteins.",
"Synonmys":"total PSA\nTotal PSA",
"NCI_code":"NCI Thesaurus Code:C94597"
},
{
"Name":"Age-Adjusted PSA",
"Definition":"Prostate-specific antigen (PSA) level defined according to specific age groups or ranges, which takes into account the natural increase of PSA levels with increased age.",
"Synonmys":"Age-Adjusted Prostate-Specific Antigen Measurement\nAge-Adjusted PSA",
"NCI_code":"NCI Thesaurus Code:C20120"
},
{
"Name":"Transition Zone PSA Density",
"Definition":"The ratio of serum PSA to transition zone volume. Takes into account the size of the prostate in determining the significance of an elevated PSA level.",
"Synonmys":"Transition Zone Prostate Specific Antigen Density\nTransition Zone PSA Density",
"NCI_code":"NCI Thesaurus Code:C20043"
},
{
"Name":"Blood Cell Count",
"Definition":"The determination of the number of red blood cells, white blood cells, and platelets in a blood sample.",
"Synonmys":"Blood Cell Count\nblood cell count\nCBC\ncomplete blood count\nComplete Blood Count\nFBC\nFull Blood Count",
"NCI_code":"NCI Thesaurus Code:C28133"
},
{
"Name":"Hemoglobin",
"Definition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the o",
"Synonmys":"Hb\nHemoglobin\nhemoglobin\nHgb",
"NCI_code":"NCI Thesaurus Code:C16676"
},
{
"Name":"Leukocyte",
"Definition":"Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system.",
"Synonmys":"leukocyte\nLEUKOCYTE\nLeukocyte\nLeukocytes\nReticuloendothelial System, Leukocytes\nWBC\nwhite blood cell\nWhite Blood Cell\nWhite Blood Cells\nWhite Blood Corpuscle\nWhite Cell",
"NCI_code":"NCI Thesaurus Code:C12529"
},
{
"Name":"Platelet ",
"Definition":"An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes.",
"Synonmys":"Bizzozero Corpuscle\nBlood Platelet\nDeetjen Body\nplatelet\nPlatelet\nPLATELET\nPlatelets\nReticuloendothelial System, Platelets\nThrombocyte\nthrombocyte\nThrombocytes",
"NCI_code":"NCI Thesaurus Code:C12520 "
},
{
"Name":"Urinalysis",
"Definition":"Laboratory analysis of urine, commonly used to aid in the diagnosis of disease or to detect the presence of a specific substance. It involves examination of the urine by physical or chemical means as ",
"Synonmys":"Urinalysis",
"NCI_code":"NCI Thesaurus Code:C17241"
},
{
"Name":"Leukocyte",
"Definition":"Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system.",
"Synonmys":"leukocyte\nLEUKOCYTE\nLeukocyte\nLeukocytes\nReticuloendothelial System, Leukocytes\nWBC\nwhite blood cell\nWhite Blood Cell\nWhite Blood Cells\nWhite Blood Corpuscle\nWhite Cell",
"NCI_code":"NCI Thesaurus Code:C12529"
},
{
"Name":"Erythrocyte",
"Definition":"Cell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm and little else; biconcave, anucleate discs, 7nm diameter in mammals.",
"Synonmys":"Blood Corpuscles\nBlood Erythrocyte\nErythrocyte\nerythrocyte\nERYTHROCYTES\nErythrocytes\nErythrocytic\nNormocyte\nRBC\nRBCs\nred blood cell\nRed Blood Cells\nRed Blood Corpuscule\nRed Cell\nRed cells\nReticuloendo",
"NCI_code":"NCI Thesaurus Code:C12521"
},
{
"Name":"Protein",
"Definition":"A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Dalt",
"Synonmys":"Protein",
"NCI_code":"NCI Thesaurus Code:C17021 "
},
{
"Name":"Blood test",
"Definition":"A blood test is a laboratory analysis performed on a blood sample that is usually extracted from a vein in the arm using a hypodermic needle, or via fingerprick. ",
"Synonmys":"Biochemical",
"NCI_code":"NCI Thesaurus Code:C25434 "
},
{
"Name":"SGPT (ALT)",
"Definition":"Activity measured as a test of liver function, human Glutamic-Pyruvate Transaminases (Alanine Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolis",
"Synonmys":"alanine transferase\nALT\nserum glutamate pyruvate transaminase\nSGPT\nSGPT (ALT)",
"NCI_code":"NCI Thesaurus Code:C25293"
},
{
"Name":"SGOT (AST)",
"Definition":"Activity measured as a test of liver function, 46\/47-kDa homodimeric human Aspartate Aminotransferases (Class-I Pyridoxal-Phosphate-Dependent Aminotransferase Family) are pyridoxal phosphate-dependent",
"Synonmys":"aspartate transaminase\nAST\nserum glutamic-oxaloacetic transaminase\nSGOT\nSGOT (AST)",
"NCI_code":"NCI Thesaurus Code:C25202"
},
{
"Name":"ALPP wt Allele",
"Definition":"Human ALPP wild-type allele is located in the vicinity of 2q37 and is approximately 4 kb in length. This allele, which encodes alkaline phosphatase, placental type protein, is involved in placental al",
"Synonmys":"Alkaline Phosphatase, Placental (Regan Isozyme) Gene\nAlkaline Phosphatase, Placental wt Allele\nALP\nALPP wt Allele\nPALP\nPLAP\nPLAP-1",
"NCI_code":"NCI Thesaurus Code:C107553 "
},
{
"Name":"Cyclic AMP Response Element",
"Definition":"A promoter sequence which interacts with CRE binding proteins to modulate gene expression in response to the level of cAMP in the cell.",
"Synonmys":"cAMP Response Element\nCRE\nCyclic AMP Response Element",
"NCI_code":"NCI Thesaurus Code:C13661"
},
{
"Name":"Blood Urea Nitrogen Measurement",
"Definition":"A quantitative measurement of the amount of urea nitrogen present in a serum sample.",
"Synonmys":"Blood Urea Nitrogen Measurement\nBUN",
"NCI_code":"NCI Thesaurus Code:C61019 "
},
{
"Name":"Lactate Dehydrogenase",
"Definition":"A family of homotetrameric cytoplasmic enzymes involved in the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. In vertebrates, genes for three different",
"Synonmys":"EC 1.1.1.27\nL-(+)-Lactate Dehydrogenase\nL-Lactic Acid Dehydrogenase\nlactate dehydrogenase\nLactate Dehydrogenase\nlactic acid dehydrogenase\nLactic Acid Dehydrogenase\nLDH\nNAD-Lactate Dehydrogenase",
"NCI_code":"NCI Thesaurus Code:C25184"
},
{
"Name":"CHO Cells",
"Definition":"The parental CHO cell line initiated from a biopsy of an ovary of an adult Chinese hamster.",
"Synonmys":"Chinese Hamster Ovary Cell\nCHO\nCHO Cells",
"NCI_code":"NCI Thesaurus Code:C17421"
},
{
"Name":"BIL",
"Definition":"NA",
"Synonmys":"RGD",
"NCI_code":"NA"
},
{
"Name":"Urea",
"Definition":"A nitrogenous compound containing a carbonyl group attached to two amine groups with osmotic diuretic activity. In vivo, urea is formed in the liver via the urea cycle from ammonia and is the final en",
"Synonmys":"Aqua Care\ncarbamide\nCarbamide\nElaqua XX\nLanaphilic\nNutraplus\nUrea\nUREA\nurea\nUreaphil\nVanamide",
"NCI_code":"NCI Thesaurus Code:C29531 "
},
{
"Name":"Calcium",
"Definition":"An element with atomic symbol Ca, atomic number 20, and atomic weight 40.08.",
"Synonmys":"Ca\nCalcium\ncalcium\nCALCIUM\nCalcium (NOS)",
"NCI_code":"NCI Thesaurus Code:C331"
},
{
"Name":"TP Mouse",
"Definition":"NA",
"Synonmys":"TP Mouse\nTP",
"NCI_code":"NCI Thesaurus Code:C14530 "
},
{
"Name":"Triglyceride Measurement",
"Definition":"A quantitative measurement of the amount of triglyceride present in a sample.",
"Synonmys":"TRIG\nTriglyceride Measurement\nTriglycerides",
"NCI_code":"NCI Thesaurus Code:C64812"
},
{
"Name":"Imaging examination",
"Definition":"Any of a number of technologies that permits the visualization and acquisition of images into a physical or electronic record.",
"Synonmys":"Imaging\nImaging Technologies\nImaging Technology",
"NCI_code":"NCI Thesaurus Code:C18843"
},
{
"Name":"Ultrasound",
"Definition":"High frequency sound, generally with a frequency greater than 20,000 Hz.",
"Synonmys":"Ultrasound",
"NCI_code":"NCI Thesaurus Code:C64384"
},
{
"Name":"Ultrasonography",
"Definition":"A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.",
"Synonmys":"2-Dimensional Grayscale Ultrasound Imaging\n2-Dimensional Ultrasound Imaging\n2D-US\nUltrasonography\nultrasonography\nULTRASOUND\nUltrasound\nultrasound\nUltrasound Imaging\nUltrasound Test\nUltrasound, Medica",
"NCI_code":"NCI Thesaurus Code:C17230 "
},
{
"Name":"Transrectal Ultrasound",
"Definition":"A procedure that uses sound waves to create a video image of the pelvic organs and tissues. A small, lubricated probe placed into the rectum releases sound waves, which create echoes as they enter a p",
"Synonmys":"endorectal ultrasound\nERUS\nTransrectal Ultrasound\ntransrectal ultrasound\nTRUS",
"NCI_code":"NCI Thesaurus Code:C18315 "
},
{
"Name":"Transabdominal Ultrasound",
"Definition":"A method of ultrasound imaging in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs.",
"Synonmys":"abdominal ultrasound\nTransabdominal Ultrasound\ntransabdominal ultrasound\nTUS",
"NCI_code":"NCI Thesaurus Code:C71375"
},
{
"Name":"Magnetic Resonance Imaging",
"Definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the",
"Synonmys":"Magnetic Resonance Imaging\nmagnetic resonance imaging\nMagnetic Resonance Imaging Scan\nMedical Imaging, Magnetic Resonance \/ Nuclear Magnetic Resonance\nMRI\nMRI Scan\nNMR Imaging\nNMRI\nNuclear Magnetic Re",
"NCI_code":"NCI Thesaurus Code:C16809"
},
{
"Name":"Multiparametric Magnetic Resonance Imaging",
"Definition":"The combination of multiple magnetic resonance techniques, including diffusion weighted imaging, dynamic contrast-enhanced imaging, and spectroscopy, to achieve an image that will allow for better ide",
"Synonmys":"MP-MRI\nMulti-parametric MRI\nMultiparametric Magnetic Resonance Imaging\nMultiparametric MRI",
"NCI_code":"NCI Thesaurus Code:C116458"
},
{
"Name":"Magnetic Resonance Spectroscopy",
"Definition":"Detection and measurement of the resonant spectra of molecular species in a tissue or sample.",
"Synonmys":"Magnetic Resonance Spectroscopy\nNMR Spectroscopy\nNUCLEAR MAGNETIC RESONANCE SPECTROSCOPY\nSpectroscopy, MR\nSpectroscopy, NMR\nSpectroscopy, Nuclear Magnetic Resonance",
"NCI_code":"NCI Thesaurus Code:C16810"
},
{
"Name":"Bone Scan",
"Definition":"A nuclear imaging method used to evaluate pathological bone metabolism.",
"Synonmys":"Bone Scan",
"NCI_code":"NCI Thesaurus Code:C17646"
},
{
"Name":"Emission computed tomography (ETC)",
"Definition":"Emission computed tomography (ECT) is a type of tomography involving radioactive emissions.",
"Synonmys":"Emission computed tomography (ETC)",
"NCI_code":"NA"
},
{
"Name":"Metastatic Malignant Neoplasm in the Bone",
"Definition":"The spread of a malignant neoplasm from a primary site to the skeletal system. The majority of metastatic neoplasms to the bone are carcinomas.",
"Synonmys":"Bone Metastases\nbone metastasis\nBone Metastasis\nMetastases to bone, NOS\nMetastatic Cancer to the Bone\nMetastatic Malignant Neoplasm in the Bone\nMetastatic Malignant Neoplasm to the Bone\nMetastatic Neo",
"NCI_code":"NCI Thesaurus Code:C3580"
},
{
"Name":"Location of metastasis",
"Definition":"NA",
"Synonmys":"Location of metastasis",
"NCI_code":"NA"
},
{
"Name":"Number of metastasis",
"Definition":"NA",
"Synonmys":"Number of metastasis",
"NCI_code":"NA"
},
{
"Name":"Chest Radiography",
"Definition":"An x-ray examination of the chest.",
"Synonmys":"Chest Radiography\nchest x-ray\nChest X-ray",
"NCI_code":"NCI Thesaurus Code:C38103"
},
{
"Name":"Pulmonary metastasis",
"Definition":"Metastatic tumour of unspecified origin in the lung.",
"Synonmys":"Pulmonary metastasis",
"NCI_code":"NA"
},
{
"Name":"Computed Tomography",
"Definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.",
"Synonmys":"CAT\nCAT Scan\nCAT scan\nComputed Tomography\ncomputed tomography\nComputerized Axial Tomography\ncomputerized axial tomography\ncomputerized tomography\nComputerized Tomography\nCT\nCT SCAN\nCT scan\ntomography",
"NCI_code":"NCI Thesaurus Code:C17204"
},
{
"Name":"Imaging examination results",
"Definition":"NA",
"Synonmys":"Imaging examination results",
"NCI_code":"NA"
},
{
"Name":"Anteroposterior diameter",
"Definition":"NA",
"Synonmys":"Anteroposterior diameter",
"NCI_code":"NA"
},
{
"Name":"Transversal diameter",
"Definition":"NA",
"Synonmys":"Transversal diameter",
"NCI_code":"NA"
},
{
"Name":"Suprainferior diameter ",
"Definition":"NA",
"Synonmys":"Suprainferior diameter ",
"NCI_code":"NA"
},
{
"Name":"Prostate volume",
"Definition":"The volume of the prostate can be estimated by the formula 0.52 × length × width × height. A volume of over 30 cm3 is regarded as prostatomegaly (enlarged prostate). ",
"Synonmys":"Prostate volume",
"NCI_code":"BioPortal cui:C1441416"
},
{
"Name":"Prostate volume",
"Definition":"NA",
"Synonmys":"Prostate volume",
"NCI_code":"NA"
},
{
"Name":"Low signal intensity lesion",
"Definition":"NA",
"Synonmys":"Low signal intensity lesion",
"NCI_code":"NA"
},
{
"Name":"Unilateral",
"Definition":"Involving only one part or side.",
"Synonmys":"Unilateral\nUNILATERAL\nUnilateral Anatomic Qualifier",
"NCI_code":"NCI Thesaurus Code:C68598"
},
{
"Name":"Bilateral",
"Definition":"Affecting both sides of the body or a matched pair of organs.",
"Synonmys":"Bilateral\nRight and Left",
"NCI_code":"NCI Thesaurus Code:C13332"
},
{
"Name":"Peripheral Zone of Prostate",
"Definition":"The region of the prostate that is located most superficial and posterior as compared to the other prostate zones. It is located closest to the rectum, and is easily palpated on digital rectal exam. T",
"Synonmys":"Peripheral Zone of Prostate",
"NCI_code":"NCI Thesaurus Code:C128570"
},
{
"Name":"Transitional Zone of the Prostatic Parenchyma",
"Definition":"The zone of the prostatic parenchyma that surrounds the proximal urethra.",
"Synonmys":"Transitional Zone of the Prostatic Parenchyma\nTZ",
"NCI_code":"NCI Thesaurus Code:C33803"
},
{
"Name":"Central Zone of Prostate",
"Definition":"This region of the prostate gland that is located between the peripheral and transition zones, surrounding the ejaculatory ducts. It gives rise to a very small percentage of prostate cancers, though t",
"Synonmys":"Central Zone of Prostate",
"NCI_code":"NCI Thesaurus Code:C128572"
},
{
"Name":"Extracapsular",
"Definition":"Definition: Situated outside of a capsule, esp. outside the capsular ligament of a joint.",
"Synonmys":"Extracapsular",
"NCI_code":"NCI Thesaurus Code:C25502"
},
{
"Name":"Seminal vesicle invasion",
"Definition":"NA",
"Synonmys":"Seminal vesicle invasion",
"NCI_code":"BioPortal cui:C1718327"
},
{
"Name":"tumor invasion of neck of bladder",
"Definition":"NA",
"Synonmys":"invasion of neck of bladder",
"NCI_code":"NA"
},
{
"Name":"Pelvic lymph node enlargement",
"Definition":"NA",
"Synonmys":"Pelvic lymph node enlargement",
"NCI_code":"NA"
},
{
"Name":"Biopsy of Prostate",
"Definition":"Removal of tissue from the prostate for microscopic examination.",
"Synonmys":"Biopsy of Prostate\nProstate Biopsy\nProstatic Biopsy",
"NCI_code":"NCI Thesaurus Code:C51701"
},
{
"Name":"Antibiotics prior to biopsy",
"Definition":"NA",
"Synonmys":"Antibiotics prior to biopsy",
"NCI_code":"NA"
},
{
"Name":"Baseline biopsy",
"Definition":"NA",
"Synonmys":"Baseline biopsy",
"NCI_code":"NA"
},
{
"Name":"Biopsy complications",
"Definition":"NA",
"Synonmys":"Biopsy complications",
"NCI_code":"NA"
},
{
"Name":"Core Biopsy",
"Definition":"The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.",
"Synonmys":"Core Biopsy\ncore needle biopsy",
"NCI_code":"NCI Thesaurus Code:C15680"
},
{
"Name":"12-Core Prostate Biopsy",
"Definition":"A prostate biopsy collection protocol that consists of sextant cores plus 6 lateral peripheral zone cores.",
"Synonmys":"12-Core Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C142182"
},
{
"Name":"8-Core Prostate Biopsy",
"Definition":"A prostate biopsy collection protocol that consists of sextant cores plus 2 lateral peripheral zone cores.",
"Synonmys":"8-Core Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C142181"
},
{
"Name":"Extended Template Biopsy",
"Definition":"Biopsy of the prostate that extends beyond the standard 10 to 12 cores.",
"Synonmys":"Extended Template Biopsy\nExtended Template Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C113105"
},
{
"Name":"Local anaesthesia prior to biopsy",
"Definition":"NA",
"Synonmys":"Local anaesthesia prior to biopsy",
"NCI_code":"NA"
},
{
"Name":"Needle Biopsy of Prostate",
"Definition":"Removal of tissue from the prostate for microscopic examination, using a needle.",
"Synonmys":"Needle Biopsy of Prostate",
"NCI_code":"NCI Thesaurus Code:C51694"
},
{
"Name":"Fine-Needle Aspiration",
"Definition":"The removal of tissue specimens or fluid from the living body with a thin needle.",
"Synonmys":"Aspirate, Fine Needle\nFINE NEEDLE ASPIRATION\nFine Needle Aspiration\nFine-Needle Aspiration\nfine-needle aspiration biopsy\nFNA\nFNA biopsy",
"NCI_code":"NCI Thesaurus Code:C15361"
},
{
"Name":"Ultrasound-guided fine-needle aspiration biopsy",
"Definition":"NA",
"Synonmys":"Ultrasound-guided fine-needle aspiration biopsy",
"NCI_code":"NA"
},
{
"Name":"Repeat biopsy after previously negative biopsy",
"Definition":"NA",
"Synonmys":"Repeat biopsy after previously negative biopsy",
"NCI_code":"NA"
},
{
"Name":"Prostate Saturation Biopsy",
"Definition":"Transperineal prostate biopsy that removes more than 20 cores. This is typically reserved for high-risk patients.",
"Synonmys":"Extensive Prostate Biopsy\nProstate Saturation Biopsy\nProstate Saturation Needle Biopsy\nSaturation Biopsy\nTransperineal Template-Guided Stereotactic Saturation Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C113288"
},
{
"Name":"Seminal Vesicle Biopsy",
"Definition":"The removal of tissue from the seminal vesicles for the purpose of microscopic evaluation.",
"Synonmys":"Seminal Vesicle Biopsy",
"NCI_code":"NCI Thesaurus Code:C94512"
},
{
"Name":"Transition zone biopsy",
"Definition":"NA",
"Synonmys":"Transition zone biopsy",
"NCI_code":"NA"
},
{
"Name":"Transperineal Biopsy",
"Definition":"A procedure in which a sample of tissue is removed from the prostate for examination under a microscope. The sample is removed with a thin needle that is inserted through the skin between the scrotum ",
"Synonmys":"Transperineal Biopsy\ntransperineal biopsy\nTransperineal Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C93199"
},
{
"Name":"Prostate Saturation Biopsy",
"Definition":"Transperineal prostate biopsy that removes more than 20 cores. This is typically reserved for high-risk patients.",
"Synonmys":"Extensive Prostate Biopsy\nProstate Saturation Biopsy\nProstate Saturation Needle Biopsy\nSaturation Biopsy\nTransperineal Template-Guided Stereotactic Saturation Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C113288"
},
{
"Name":"Transrectal Biopsy",
"Definition":"A procedure in which a sample of tissue is removed from the prostate using a thin needle that is inserted through the rectum and into the prostate. Transrectal ultrasound (TRUS) is usually used to gui",
"Synonmys":"Transrectal Biopsy\ntransrectal biopsy\nTransrectal Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C93200"
},
{
"Name":"Transrectal Ultrasonography Guided Biopsy",
"Definition":"A procedure that uses transrectal ultrasound to image the prostate and guide the placement of a biopsy needles to obtain a tissue sample.",
"Synonmys":"Transrectal Ultrasonography Guided Biopsy\nTRUS Biopsy\nTRUS-Guided Biopsy",
"NCI_code":"NCI Thesaurus Code:C143148"
},
{
"Name":"Transurethral Biopsy",
"Definition":"A procedure in which a sample of tissue is removed from the prostate for examination under a microscope. A thin, lighted tube is inserted through the urethra into the prostate, and a small piece of ti",
"Synonmys":"Transurethral Biopsy\ntransurethral biopsy\nTransurethral Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C93198"
},
{
"Name":"Diagnostic transurethral resection of the prostate",
"Definition":"NA",
"Synonmys":"Diagnostic transurethral resection of the prostate",
"NCI_code":"NA"
},
{
"Name":"Ultrasound-Guided Prostate Biopsy",
"Definition":"A diagnostic procedure that uses an ultrasound image to guide the placement of a biopsy needle into the prostate to obtain a tissue sample.",
"Synonmys":"Ultrasound-Guided Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C116510"
},
{
"Name":"Contrast-Enhanced Ultrasound-Guided Prostate Biops",
"Definition":"A radiologic technique that employs contrast agents to enable a more precise needle placement during a biopsy of the prostate.",
"Synonmys":"Contrast-Enhanced Ultrasound-Guided Prostate Biopsy",
"NCI_code":"NCI Thesaurus Code:C116511"
},
{
"Name":"Histopathology of radical prostatectomy specimens",
"Definition":"NA",
"Synonmys":"Histopathology of radical prostatectomy specimens",
"NCI_code":"NA"
},
{
"Name":"Processing of radical prostatectomy specimens",
"Definition":"NA",
"Synonmys":"Processing of radical prostatectomy specimens",
"NCI_code":"NA"
},
{
"Name":"Prostate cancer volume",
"Definition":"NA",
"Synonmys":"Prostate cancer volume",
"NCI_code":"NA"
},
{
"Name":"Radical prostatectomy specimen report",
"Definition":"NA",
"Synonmys":"Radical prostatectomy specimen report",
"NCI_code":"NA"
},
{
"Name":"Surgical Margins Status",
"Definition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.",
"Synonmys":"SGMGSTAT\nSurgical Margins Status",
"NCI_code":"NCI Thesaurus Code:C123560"
},
{
"Name":"Pathology of prostate needle biopsies",
"Definition":"NA",
"Synonmys":"Pathology of prostate needle biopsies",
"NCI_code":"NA"
},
{
"Name":"Gleason Score for Prostate Cancer",
"Definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of p",
"Synonmys":"Gleason score\nGleason Score\nGleason Score for Prostate Cancer\nGleason Sum",
"NCI_code":"NCI Thesaurus Code:C28084"
},
{
"Name":"Primary Gleason Pattern",
"Definition":"The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns.",
"Synonmys":"GLEASON PRIMARY SCORE\nPrimary Gleason Pattern",
"NCI_code":"NCI Thesaurus Code:C48603"
},
{
"Name":"Secondary Gleason Pattern",
"Definition":"The second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patt",
"Synonmys":"GLEASON PRIMARY SCORE\nPrimary Gleason Pattern",
"NCI_code":"NCI Thesaurus Code:C48604"
},
{
"Name":"Total Gleason Score for Prostate Cancer",
"Definition":"The value of the sum of the primary and secondary Gleason scores (range 2-10). If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiat",
"Synonmys":"GLEASON TOTAL SUM\nTotal Gleason Score\nTotal Gleason Score for Prostate Cancer",
"NCI_code":"NCI Thesaurus Code:C48602"
},
{
"Name":"TNM Prostate tumor staging",
"Definition":"NA",
"Synonmys":"Tumor-node-metastasis (TNM) Prostate tumor staging",
"NCI_code":"BioPortal cui:C0474935"
},
{
"Name":"T-staging",
"Definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involve",
"Synonmys":"T-staging",
"NCI_code":"NA"
},
{
"Name":"TX Stage Finding",
"Definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.",
"Synonmys":"Tumor Stage TX\nTX\nTX Cancer Stage Finding\nTX Primary Tumor Finding\nTX Primary Tumor Stage Finding\nTX Stage\nTX Stage Finding\nTX TNM Finding\nTX Tumor Finding\nTX Tumor Stage",
"NCI_code":"NCI Thesaurus Code:C48737 "
},
{
"Name":"T0 Stage Finding",
"Definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.",
"Synonmys":"T0\nT0 Cancer Stage Finding\nT0 Primary Tumor Finding\nT0 Primary Tumor Stage Finding\nT0 Stage\nT0 Stage Finding\nT0 TNM Finding\nT0 Tumor Finding\nT0 Tumor Stage\nTumor Stage T0",
"NCI_code":"NCI Thesaurus Code:C48719"
},
{
"Name":"T1 Stage Finding",
"Definition":"A clinical and\/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.",
"Synonmys":"T1\nT1 Cancer Stage Finding\nT1 Primary Tumor Finding\nT1 Primary Tumor Stage Finding\nT1 Stage\nT1 Stage Finding\nT1 TNM Finding\nT1 Tumor Finding\nT1 Tumor Stage\nTumor Stage T1",
"NCI_code":"NCI Thesaurus Code:C48720 "
},
{
"Name":"T1a Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, f",
"Synonmys":"T1a\nT1a Cancer Stage Finding\nT1a Primary Tumor Finding\nT1a Primary Tumor Stage Finding\nT1a Stage\nT1a Stage Finding\nT1a TNM Finding\nT1a Tumor Finding\nT1a Tumor Stage\nTumor Stage T1a",
"NCI_code":"NCI Thesaurus Code:C48721"
},
{
"Name":"T1b Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, f",
"Synonmys":"T1b\nT1b Cancer Stage Finding\nT1b Primary Tumor Finding\nT1b Primary Tumor Stage Finding\nT1b Stage\nT1b Stage Finding\nT1b TNM Finding\nT1b Tumor Finding\nT1b Tumor Stage\nTumor Stage T1b",
"NCI_code":"NCI Thesaurus Code:C48722"
},
{
"Name":"T1c Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, f",
"Synonmys":"T1c\nT1c Cancer Stage Finding\nT1c Primary Tumor Finding\nT1c Primary Tumor Stage Finding\nT1c Stage\nT1c Stage Finding\nT1c TNM Finding\nT1c Tumor Finding\nT1c Tumor Stage\nTumor Stage T1c",
"NCI_code":"NCI Thesaurus Code:C48723"
},
{
"Name":"T2 Stage Finding",
"Definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding d",
"Synonmys":"T2\nT2 Cancer Stage Finding\nT2 Primary Tumor Finding\nT2 Primary Tumor Stage Finding\nT2 Stage\nT2 Stage Finding\nT2 TNM Finding\nT2 Tumor Finding\nT2 Tumor Stage\nTumor Stage T2",
"NCI_code":"NCI Thesaurus Code:C48724"
},
{
"Name":"T2a Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM findin",
"Synonmys":"T2a\nT2a Cancer Stage Finding\nT2a Primary Tumor Finding\nT2a Primary Tumor Stage Finding\nT2a Stage\nT2a Stage Finding\nT2a TNM Finding\nT2a Tumor Finding\nT2a Tumor Stage\nTumor Stage T2a",
"NCI_code":"NCI Thesaurus Code:C48725"
},
{
"Name":"T2b Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM findin",
"Synonmys":"T2b\nT2b Cancer Stage Finding\nT2b Primary Tumor Finding\nT2b Primary Tumor Stage Finding\nT2b Stage\nT2b Stage Finding\nT2b TNM Finding\nT2b Tumor Finding\nT2b Tumor Stage\nTumor Stage T2b",
"NCI_code":"NCI Thesaurus Code:C48726"
},
{
"Name":"T2c Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM findin",
"Synonmys":"T2c\nT2c Cancer Stage Finding\nT2c Primary Tumor Finding\nT2c Primary Tumor Stage Finding\nT2c Stage\nT2c Stage Finding\nT2c TNM Finding\nT2c Tumor Finding\nT2c Tumor Stage\nTumor Stage T2c",
"NCI_code":"NCI Thesaurus Code:C48727"
},
{
"Name":"T3 Stage Finding",
"Definition":"A clinical and\/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.",
"Synonmys":"T3\nT3 Cancer Stage Finding\nT3 Primary Tumor Finding\nT3 Primary Tumor Stage Finding\nT3 Stage\nT3 Stage Finding\nT3 TNM Finding\nT3 Tumor Finding\nT3 Tumor Stage\nTumor Stage T3",
"NCI_code":"NCI Thesaurus Code:C48728"
},
{
"Name":"T3a Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it ",
"Synonmys":"T3a\nT3a Cancer Stage Finding\nT3a Primary Tumor Finding\nT3a Primary Tumor Stage Finding\nT3a Stage\nT3a Stage Finding\nT3a TNM Finding\nT3a Tumor Finding\nT3a Tumor Stage\nTumor Stage T3a",
"NCI_code":"NCI Thesaurus Code:C48729"
},
{
"Name":"T3b Stage Finding",
"Definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it ",
"Synonmys":"T3b\nT3b Cancer Stage Finding\nT3b Primary Tumor Finding\nT3b Primary Tumor Stage Finding\nT3b Stage\nT3b Stage Finding\nT3b TNM Finding\nT3b Tumor Finding\nT3b Tumor Stage\nTumor Stage T3b",
"NCI_code":"NCI Thesaurus Code:C48730"
},
{
"Name":"T4 Stage Finding",
"Definition":"A clinical and\/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.",
"Synonmys":"T4\nT4 Cancer Stage Finding\nT4 Primary Tumor Finding\nT4 Primary Tumor Stage Finding\nT4 Stage\nT4 Stage Finding\nT4 TNM Finding\nT4 Tumor Finding\nT4 Tumor Stage\nTumor Stage T4",
"NCI_code":"NCI Thesaurus Code:C48732 "
},
{
"Name":"pT2 Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT2 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 stage finding is defin",
"Synonmys":"pT2\npT2 Cancer Stage Finding\npT2 Primary Tumor Finding\npT2 Primary Tumor Stage Finding\npT2 Stage\npT2 Stage Finding\npT2 TNM Finding\npT2 Tumor Finding\npT2 Tumor Stage\nTumor Stage pT2",
"NCI_code":"NCI Thesaurus Code:C48764"
},
{
"Name":"pT2a Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT2a stage finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2a stage finding is d",
"Synonmys":"pT2a\npT2a Cancer Stage Finding\npT2a Primary Tumor Finding\npT2a Primary Tumor Stage Finding\npT2a Stage\npT2a Stage Finding\npT2a TNM Finding\npT2a Tumor Finding\npT2a Tumor Stage\nTumor Stage pT2a",
"NCI_code":"NCI Thesaurus Code:C48765"
},
{
"Name":"pT2b Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT2b stage finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2b stage finding is d",
"Synonmys":"pT2b\npT2b Cancer Stage Finding\npT2b Primary Tumor Finding\npT2b Primary Tumor Stage Finding\npT2b Stage\npT2b Stage Finding\npT2b TNM Finding\npT2b Tumor Finding\npT2b Tumor Stage\nTumor Stage pT2b",
"NCI_code":"NCI Thesaurus Code:C48766"
},
{
"Name":"pT2c Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT2c stage finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2c stage finding is d",
"Synonmys":"pT2c\npT2c Cancer Stage Finding\npT2c Primary Tumor Finding\npT2c Primary Tumor Stage Finding\npT2c Stage\npT2c Stage Finding\npT2c TNM Finding\npT2c Tumor Finding\npT2c Tumor Stage\nTumor Stage pT2c",
"NCI_code":"NCI Thesaurus Code:C48767"
},
{
"Name":"pT3 Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT3 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 stage finding is defin",
"Synonmys":"pT3\npT3 Cancer Stage Finding\npT3 Primary Tumor Finding\npT3 Primary Tumor Stage Finding\npT3 Stage\npT3 Stage Finding\npT3 TNM Finding\npT3 Tumor Finding\npT3 Tumor Stage\nTumor Stage pT3",
"NCI_code":"NCI Thesaurus Code:C48768"
},
{
"Name":"pT3a Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT3a stage finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3a stage finding is d",
"Synonmys":"pT3a\npT3a Cancer Stage Finding\npT3a Primary Tumor Finding\npT3a Primary Tumor Stage Finding\npT3a Stage\npT3a Stage Finding\npT3a TNM Finding\npT3a Tumor Finding\npT3a Tumor Stage\nTumor Stage pT3a",
"NCI_code":"NCI Thesaurus Code:C48769"
},
{
"Name":"pT3b Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT3b stage finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3b stage finding is d",
"Synonmys":"pT3b\npT3b Cancer Stage Finding\npT3b Primary Tumor Finding\npT3b Primary Tumor Stage Finding\npT3b Stage\npT3b Stage Finding\npT3b TNM Finding\npT3b Tumor Finding\npT3b Tumor Stage\nTumor Stage pT3b",
"NCI_code":"NCI Thesaurus Code:C48770"
},
{
"Name":"pT4 Stage Finding",
"Definition":"A pathologic primary tumor TNM stage finding. The definition of pT4 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 stage finding is defin",
"Synonmys":"pT4\npT4 Cancer Stage Finding\npT4 Primary Tumor Finding\npT4 Primary Tumor Stage Finding\npT4 Stage\npT4 Stage Finding\npT4 TNM Finding\npT4 Tumor Finding\npT4 Tumor Stage\nTumor Stage pT4",
"NCI_code":"NCI Thesaurus Code:C48772"
},
{
"Name":"N-staging",
"Definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involve",
"Synonmys":"N-staging",
"NCI_code":"NA"
},
{
"Name":"NX Stage Finding",
"Definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.",
"Synonmys":"Lymph Node Stage NX\nNode Stage NX\nNX\nNX Cancer Stage Finding\nNX Lymph Node Finding\nNX Lymph Node Stage\nNX Node Finding\nNX Node Stage\nNX Regional Lymph Node Stage Finding\nNX Regional Lymph Nodes Findin",
"NCI_code":"NCI Thesaurus Code:C48718"
},
{
"Name":"N0 Stage Finding",
"Definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.",
"Synonmys":"Lymph Node Stage N0\nN0\nN0 Cancer Stage Finding\nN0 Lymph Node Finding\nN0 Lymph Node Stage\nN0 Node Finding\nN0 Node Stage\nN0 Regional Lymph Node Stage Finding\nN0 Regional Lymph Nodes Finding\nN0 Stage\nN0 ",
"NCI_code":"NCI Thesaurus Code:C48705"
},
{
"Name":"N1 Stage Finding",
"Definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it re",
"Synonmys":"Lymph Node Stage N1\nN1\nN1 Cancer Stage Finding\nN1 Lymph Node Finding\nN1 Lymph Node Stage\nN1 Node Finding\nN1 Node Stage\nN1 Regional Lymph Node Stage Finding\nN1 Regional Lymph Nodes Finding\nN1 Stage\nN1 ",
"NCI_code":"NCI Thesaurus Code:C48706"
},
{
"Name":"pNX TNM Finding",
"Definition":"Prostate cancer in which the regional lymph nodes were not sampled. (from AJCC 6th and 7th Eds.)",
"Synonmys":"pNX Cancer of Prostate\npNX Cancer of the Prostate\npNX Carcinoma of Prostate\npNX Carcinoma of the Prostate\npNX Prostate Cancer\npNX Prostate Carcinoma\nProstate Cancer pNX TNM Finding\nProstate Cancer pNX",
"NCI_code":"NCI Thesaurus Code:C52682"
},
{
"Name":"pN0 Stage Finding",
"Definition":"No morphologic evidence of regional lymph node metastasis by routine histologic staining, in accordance with TNM classification system guidelines.",
"Synonmys":"Lymph Node Stage pN0\nNode Stage pN0\npN0\npN0 Cancer Stage Finding\npN0 Lymph Node Finding\npN0 Lymph Node Stage\npN0 Node Finding\npN0 Node Stage\npN0 Regional Lymph Node Stage Finding\npN0 Regional Lymph No",
"NCI_code":"NCI Thesaurus Code:C48745"
},
{
"Name":"pN1 Stage Finding",
"Definition":"NA",
"Synonmys":"Lymph Node Stage pN1\nNode Stage pN1\npN1\npN1 Cancer Stage Finding\npN1 Lymph Node Finding\npN1 Lymph Node Stage\npN1 Node Finding\npN1 Node Stage\npN1 Regional Lymph Node Stage Finding\npN1 Regional Lymph No",
"NCI_code":"NCI Thesaurus Code:C48746"
},
{
"Name":"M-staging",
"Definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involve",
"Synonmys":"metastasis staging",
"NCI_code":"NA"
},
{
"Name":"MX Stage Finding",
"Definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.",
"Synonmys":"Metastasis Stage MX\nMX\nMX Cancer Stage Finding\nMX Distant Metastasis Finding\nMX Distant Metastasis Stage Finding\nMX Metastasis Finding\nMX Metastasis Stage\nMX Stage\nMX Stage Finding\nMX TNM Finding",
"NCI_code":"NCI Thesaurus Code:C48704"
},
{
"Name":"M0 Stage Finding",
"Definition":"A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.",
"Synonmys":"M0\nM0 Cancer Stage Finding\nM0 Distant Metastasis Finding\nM0 Distant Metastasis Stage Finding\nM0 Metastasis Finding\nM0 Metastasis Stage\nM0 Stage\nM0 Stage Finding\nM0 TNM Finding\nMetastasis Stage M0",
"NCI_code":"NCI Thesaurus Code:C48699"
},
{
"Name":"M1 Stage Finding",
"Definition":"A clinical and\/or pathologic distant metastasis TNM finding indicating the spread of cancer to distant anatomic sites.",
"Synonmys":"M1\nM1 Cancer Stage Finding\nM1 Distant Metastasis Finding\nM1 Distant Metastasis Stage Finding\nM1 Metastasis Finding\nM1 Metastasis Stage\nM1 Stage\nM1 Stage Finding\nM1 TNM Finding\nMetastasis Stage M1",
"NCI_code":"NCI Thesaurus Code:C48700"
},
{
"Name":"M1a Stage Finding",
"Definition":"A TNM finding indicating the spread of cancer to distant anatomic sites. The definition of M1a TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer ",
"Synonmys":"M1a\nM1a Cancer Stage Finding\nM1a Distant Metastasis Finding\nM1a Distant Metastasis Stage Finding\nM1a Metastasis Finding\nM1a Metastasis Stage\nM1a Stage\nM1a Stage Finding\nM1a TNM Finding\nMetastasis Stag",
"NCI_code":"NCI Thesaurus Code:C48701 "
},
{
"Name":"M1b Stage Finding",
"Definition":"A TNM finding indicating the spread of cancer to distant anatomic sites. The definition of M1b TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer ",
"Synonmys":"M1b\nM1b Cancer Stage Finding\nM1b Distant Metastasis Finding\nM1b Distant Metastasis Stage Finding\nM1b Metastasis Finding\nM1b Metastasis Stage\nM1b Stage\nM1b Stage Finding\nM1b TNM Finding\nMetastasis Stag",
"NCI_code":"NCI Thesaurus Code:C48702"
},
{
"Name":"M1c Stage Finding",
"Definition":"A TNM finding indicating the spread of cancer to distant anatomic sites. The definition of M1c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it",
"Synonmys":"M1c\nM1c Cancer Stage Finding\nM1c Distant Metastasis Finding\nM1c Distant Metastasis Stage Finding\nM1c Metastasis Finding\nM1c Metastasis Stage\nM1c Stage\nM1c Stage Finding\nM1c TNM Finding\nMetastasis Stag",
"NCI_code":"NCI Thesaurus Code:C48703"
},
{
"Name":"Prostate Cancer by AJCC v6 Stage",
"Definition":"A term that refers to the staging of prostate carcinoma according to the American Joint Committee on Cancer, 6th edition.",
"Synonmys":"Prostate Cancer by AJCC v6 Stage\nProstate Carcinoma by AJCC v6 Stage",
"NCI_code":"NCI Thesaurus Code:C90521"
},
{
"Name":"Stage I Prostate Cancer AJCC v6",
"Definition":"Stage I includes: T1, N0, M0, G1. T1: Tumor invades subepithelial connective tissue. N0: No regional metastasis. M0: No distant metastasis. G1: Well differentiated (slight anaplasia) (Gleason 2-4). (A",
"Synonmys":"Cancer of Prostate Stage I AJCC v6\nCancer of the Prostate Stage I AJCC v6\nProstate Cancer Stage I AJCC v6\nProstate Carcinoma Stage I AJCC v6\nStage I Cancer of Prostate AJCC v6\nStage I Cancer of the Pr",
"NCI_code":"NCI Thesaurus Code:C7555"
},
{
"Name":"Stage II Prostate Cancer AJCC v6",
"Definition":"Stage II includes: (T1a, N0, M0, G2, 3-4); (T1b, N0, M0, Any G); (T1c, N0, M0, Any G); (T1, N0, M0, Any G); (T2, N0, M0, Any G). T1: Clinically inapparent tumor neither palpable nor visible by imaging",
"Synonmys":"Cancer of Prostate Stage II AJCC v6\nCancer of the Prostate Stage II AJCC v6\nProstate Cancer Stage II AJCC v6\nProstate Carcinoma Stage II AJCC v6\nStage II Cancer of Prostate AJCC v6\nStage II Cancer of ",
"NCI_code":"NCI Thesaurus Code:C7553"
},
{
"Name":"Stage III Prostate Cancer AJCC v6",
"Definition":"Stage III includes: T3, N0, M0, Any G. T3: Tumor extends through the prostatic capsule. T3a: Extracapsular extension (unilateral or bilateral). T3b: Tumor invades seminal vesicle(s). N0: No regional l",
"Synonmys":"Cancer of Prostate Stage III AJCC v6\nCancer of the Prostate Stage III AJCC v6\nProstate Cancer Stage III AJCC v6\nProstate Carcinoma Stage III AJCC v6\nStage III Cancer of Prostate AJCC v6\nStage III Canc",
"NCI_code":"NCI Thesaurus Code:C7551"
},
{
"Name":"Stage IV Prostate Cancer AJCC v6",
"Definition":"Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, Any N, M1) (Any G). T4: Tumor is fixed or invades adjacent structures other than seminal vesicles: bladder neck, external sphincter, rectum, l",
"Synonmys":"Cancer of Prostate Stage IV AJCC v6\nCancer of the Prostate Stage IV AJCC v6\nProstate Cancer Stage IV AJCC v6\nProstate Carcinoma Stage IV AJCC v6\nStage IV Cancer of Prostate AJCC v6\nStage IV Cancer of ",
"NCI_code":"NCI Thesaurus Code:C9075"
},
{
"Name":"Prostate Cancer by AJCC v8 Stage",
"Definition":"A term that refers to the staging of prostate cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas and squamous cell carcinomas of th",
"Synonmys":"Prostate Cancer by AJCC v8 Stage\nProstate Carcinoma by AJCC v8 Stage",
"NCI_code":"NCI Thesaurus Code:C140163"
},
{
"Name":"Stage I Prostate Cancer AJCC v8",
"Definition":"Stage I includes: (cT1a-c, cT2a, N0, M0, PSA less than 10, Grade Group 1); (pT2, N0, M0, PSA less than 10, Grade Group 1). cT1a: Prostate cancer in which the tumor is an incidental histologic finding ",
"Synonmys":"Stage I Prostate Cancer\nStage I Prostate Cancer AJCC v8\nStage I Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140164"
},
{
"Name":"Stage II Prostate Cancer AJCC v8",
"Definition":"Stage II includes: IIA: (cT1a-c, cT2a, N0, M0, PSA equal or more than 10 and less than 20, Grade Group 1); (cT2b-c, N0, M0, PSA less than 20, Grade Group 1); IIB: T1-2, N0, M0, PSA less than 20, Grade",
"Synonmys":"Stage II Prostate Cancer\nStage II Prostate Cancer AJCC v8\nStage II Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140165"
},
{
"Name":"Stage IIA Prostate Cancer AJCC v8",
"Definition":"Stage IIA includes: (cT1a-c, cT2a, N0, M0, PSA equal or more than 10 and less than 20, Grade Group 1); (cT2b-c, N0, M0, PSA less than 20, Grade Group 1). cT1a: Prostate cancer in which the tumor is an",
"Synonmys":"Stage IIA Prostate Cancer\nStage IIA Prostate Cancer AJCC v8\nStage IIA Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140166 "
},
{
"Name":"Stage IIB Prostate Cancer AJCC v8",
"Definition":"Stage IIB includes: T1-2, N0, M0, PSA less than 20, Grade Group 2. T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and con",
"Synonmys":"Stage IIB Prostate Cancer\nStage IIB Prostate Cancer AJCC v8\nStage IIB Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140167"
},
{
"Name":"Stage IIC Prostate Cancer AJCC v8",
"Definition":"Stage IIC includes: (T1-2, N0, M0, PSA less than 20, Grade Group 3); (T1-2, N0, M0, PSA less than 20, Grade Group 4). T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Pro",
"Synonmys":"Stage IIC Prostate Cancer\nStage IIC Prostate Cancer AJCC v8\nStage IIC Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140168"
},
{
"Name":"Stage III Prostate Cancer AJCC v8",
"Definition":"Stage III includes: IIIA: T1-2, N0, M0, PSA 20 or more, Grade Group 1-4; IIIB: T3-4, N0, M0, PSA: Any, Grade Group 1-4; IIIC: Any T, N0, M0, PSA: Any, Grade Group 5. T1: Prostate cancer with clinicall",
"Synonmys":"Stage III Prostate Cancer\nStage III Prostate Cancer AJCC v8\nStage III Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140169"
},
{
"Name":"Stage IIIA Prostate Cancer AJCC v8",
"Definition":"Stage IIIA includes: T1-2, N0, M0, PSA 20 or more, Grade Group 1-4; T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and co",
"Synonmys":"Stage IIIA Prostate Cancer\nStage IIIA Prostate Cancer AJCC v8\nStage IIIA Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140170"
},
{
"Name":"Stage IIIB Prostate Cancer AJCC v8",
"Definition":"Stage IIIB includes: T3-4, N0, M0, PSA: Any, Grade Group 1-4; T3: Prostate cancer with extraprostatic tumor that is not fixed or does not invade adjacent structures. T4: Prostate cancer in which the t",
"Synonmys":"Stage IIIB Prostate Cancer\nStage IIIB Prostate Cancer AJCC v8\nStage IIIB Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140171"
},
{
"Name":"Stage IIIC Prostate Cancer AJCC v8",
"Definition":"Stage IIIC includes: Any T, N0, M0, PSA: Any, Grade Group 5. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 5: Gleason Sco",
"Synonmys":"Stage IIIC Prostate Cancer\nStage IIIC Prostate Cancer AJCC v8\nStage IIIC Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140172"
},
{
"Name":"Stage IV Prostate Cancer AJCC v8",
"Definition":"Stage IV includes: IVA: Any T, N1, M0, PSA: Any, Grade Group: Any; IVB: Any T, N0, M1, PSA: Any, Grade Group: Any. N0: Prostate cancer with no positive regional nodes. N1: Prostate cancer with metasta",
"Synonmys":"Stage IV Prostate Cancer\nStage IV Prostate Cancer AJCC v8\nStage IV Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140173"
},
{
"Name":"Stage IVA Prostate Cancer AJCC v8",
"Definition":"Stage IVA includes: Any T, N1, M0, PSA: Any, Grade Group: Any. N1: Prostate cancer with metastases in regional node(s). M0: Prostate cancer without evidence of distant metastasis. (AJCC 8th ed.)",
"Synonmys":"Stage IVA Prostate Cancer\nStage IVA Prostate Cancer AJCC v8\nStage IVA Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140174 "
},
{
"Name":"Stage IVB Prostate Cancer AJCC v8",
"Definition":"Stage IVB includes: Any T, N0, M1, PSA: Any, Grade Group: Any. N0: Prostate cancer with no positive regional nodes. M1: Prostate cancer with distant metastasis. (AJCC 8th ed.)",
"Synonmys":"Stage IVB Prostate Cancer\nStage IVB Prostate Cancer AJCC v8\nStage IVB Prostate Carcinoma AJCC v8",
"NCI_code":"NCI Thesaurus Code:C140175"
},
{
"Name":"Screening for Prostate Cancer",
"Definition":"NA",
"Synonmys":"early detection of prostate cancer\nprostate cancer early detection\nprostate cancer screening\nScreening for Prostate Cancer",
"NCI_code":"NCI Thesaurus Code:C15550"
},
{
"Name":"Quality adjusted life years",
"Definition":"NA",
"Synonmys":"QUALY - Quality adjusted life years",
"NCI_code":"BioPortal cui:C0080071"
},
{
"Name":"Therapeutic Procedure",
"Definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.",
"Synonmys":"therapeutic intervention\nTherapeutic Interventions\nTherapeutic Method\nTherapeutic Procedure\nTherapeutic Technique\nTherapy\ntherapy\nTREAT\nTreatment\nTX",
"NCI_code":"NCI Thesaurus Code:C49236"
},
{
"Name":"Deferred treatment",
"Definition":"NA",
"Synonmys":"Deferred treatment",
"NCI_code":"NA"
},
{
"Name":"Patient Observation",
"Definition":"Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surg",
"Synonmys":"Active Surveillance\nactive surveillance\ndeferred therapy\nexpectant management\nobservation\nObservation\nPatient Observation\nWatchful Waiting\nwatchful waiting",
"NCI_code":"NCI Thesaurus Code:C15722"
},
{
"Name":"Patient Observation",
"Definition":"Closely watching a patient's condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surg",
"Synonmys":"Active Surveillance\nactive surveillance\ndeferred therapy\nexpectant management\nobservation\nObservation\nPatient Observation\nWatchful Waiting\nwatchful waiting",
"NCI_code":"NCI Thesaurus Code:C15723"
},
{
"Name":"Surgery",
"Definition":"The branch of medical science that treats disease or injury by operative procedures.",
"Synonmys":"Surgery",
"NCI_code":"NCI Thesaurus Code:C17173"
},
{
"Name":"Radical Prostatectomy",
"Definition":"The surgical removal of all of the prostate as well as some surrounding tissue, including lymph nodes.",
"Synonmys":"Prostatovesiculectomy\nRadical Prostatectomy\nradical prostatectomy",
"NCI_code":"NCI Thesaurus Code:C15399"
},
{
"Name":"Open Prostatectomy",
"Definition":"An operation to remove part or all of the prostate gland through an incision in the lower abdomen or perineum (the area between the anus and scrotum). An open prostatectomy may be done to remove an en",
"Synonmys":"Open Prostatectomy\nopen prostatectomy",
"NCI_code":"NCI Thesaurus Code:C92983"
},
{
"Name":"Radical Retropubic Prostatectomy",
"Definition":"Surgery to remove all of the prostate and nearby lymph nodes through an incision in the wall of the abdomen.",
"Synonmys":"Radical Retropubic Prostatectomy\nradical retropubic prostatectomy\nRRP\n",
"NCI_code":"NCI Thesaurus Code:C51884"
},
{
"Name":"Nerve-Sparing Surgery",
"Definition":"Any surgery that attempts to preserve nerve function near the surgery site.",
"Synonmys":"Nerve-Sparing Surgery",
"NCI_code":"NCI Thesaurus Code:C113420"
},
{
"Name":"Pelvic Lymphadenectomy",
"Definition":"Surgical removal of one or more pelvic lymph nodes.",
"Synonmys":"Excision Pelvic Lymph Nodes\nPelvic Lymph Node Dissection\nPelvic Lymphadenectomy\npelvic lymphadenectomy",
"NCI_code":"NCI Thesaurus Code:C51896"
},
{
"Name":"Pelvic node sampling",
"Definition":"NA",
"Synonmys":"Pelvic node sampling",
"NCI_code":"NA"
},
{
"Name":"Radical prostatectomy without pelvic node excision",
"Definition":"NA",
"Synonmys":"Radical prostatectomy without pelvic node excision",
"NCI_code":"NA"
},
{
"Name":"Radical Perineal Prostatectomy",
"Definition":"Surgery to remove all of the prostate through an incision between the scrotum and the anus. Nearby lymph nodes are sometimes removed through a separate incision in the wall of the abdomen.",
"Synonmys":"radical perineal prostatectomy\nRadical Perineal Prostatectomy",
"NCI_code":"NCI Thesaurus Code:C94451"
},
{
"Name":"Suprapubic Prostatectomy",
"Definition":"Removal of prostate tissue following a midline abdominal incision from the umbilicus to the pubic area and a small incision of the lower anterior bladder wall.",
"Synonmys":"Suprapubic Prostatectomy",
"NCI_code":"NCI Thesaurus Code:C51589"
},
{
"Name":"Radical laparoscopic prostatectomy",
"Definition":"NA",
"Synonmys":"Radical laparoscopic prostatectomy",
"NCI_code":"NA"
},
{
"Name":"Robot assisted laparoscopic radical prostatectomy",
"Definition":"NA",
"Synonmys":"Robot assisted laparoscopic radical prostatectomy",
"NCI_code":"NA"
},
{
"Name":"Radical Cystoprostatectomy",
"Definition":"The simultaneous surgical resection of the urinary bladder and prostate gland with pelvic lymphadenectomy.",
"Synonmys":"cystoprostatectomy\nCystoprostatectomy\nRadical Cystoprostatectomy",
"NCI_code":"NCI Thesaurus Code:C51899"
},
{
"Name":"Radical cystoprostatourethrectomy",
"Definition":"NA",
"Synonmys":"Radical cystoprostatourethrectomy",
"NCI_code":"NA"
},
{
"Name":"Salvage cystoprostatectomy",
"Definition":"NA",
"Synonmys":"Salvage cystoprostatectomy",
"NCI_code":"NA"
},
{
"Name":"Salvage cystoprostatourethrectomy",
"Definition":"NA",
"Synonmys":"Salvage cystoprostatourethrectomy",
"NCI_code":"NA"
},
{
"Name":"Transurethral Microwave Thermotherapy of the Prost",
"Definition":"A procedure for treatment of benign prostatic hypertrophy that uses microwave energy delivered through the urethra to destroy prostate tissue.",
"Synonmys":"Transurethral Microwave Thermotherapy of the Prostate\nTUMT",
"NCI_code":"NCI Thesaurus Code:C89823"
},
{
"Name":"Transurethral Needle Ablation of the Prostate",
"Definition":"A procedure for treatment of benign prostatic hypertrophy that uses low energy radio frequency energy delivered through the urethra to destroy prostate tissue.\/NCI-GLOSS Definition: A procedure that i",
"Synonmys":"transurethral needle ablation\nTransurethral Needle Ablation of the Prostate\ntransurethral radiofrequency ablation\nTUNA",
"NCI_code":"NCI Thesaurus Code:C89821"
},
{
"Name":"Transurethral Prostatic Resection",
"Definition":"Prostate tissue removal via a cystoscope.|NCI-GLOSS Definition: Surgery to remove tissue from the prostate using an instrument inserted through the urethra.",
"Synonmys":"Prostate Transurethral Resection\nTransurethral Prostatectomy\nTransurethral Prostatic Resection\nTransurethral Resection of Prostate\ntransurethral resection of the prostate\nTransurethral Resection of th",
"NCI_code":"NCI Thesaurus Code:C15343"
},
{
"Name":"Transurethral Electrovaporization of the Prostate",
"Definition":"Application of electrical energy to electrosurgically vaporize or remove the obstructive enlarged prostatic tissue. In electrosurgical vaporization, the electrode rapidly heats the tissue cells so tha",
"Synonmys":"Transurethral Electrovaporization of the Prostate\nTUVP",
"NCI_code":"NCI Thesaurus Code:C16188"
},
{
"Name":"Complications of Radical prostatectomy",
"Definition":"NA",
"Synonmys":"Complications of RP",
"NCI_code":"NA"
},
{
"Name":"Other surgery",
"Definition":"NA",
"Synonmys":"Other surgery",
"NCI_code":"NA"
},
{
"Name":"Extented pelvic lymph node dissection (eLND)",
"Definition":"NA",
"Synonmys":"Extented pelvic lymph node dissection (eLND)",
"NCI_code":"NA"
},
{
"Name":"Extented lymph node dissection",
"Definition":"NA",
"Synonmys":"Extented lymph node dissection",
"NCI_code":"NA"
},
{
"Name":"Therapeutic role of extended lymph node dissection",
"Definition":"NA",
"Synonmys":"Therapeutic role of extended lymph node dissection (eLND)",
"NCI_code":"NA"
},
{
"Name":"Neoadjuvant and adjuvant hormonal therapy and radi",
"Definition":"Neoadjuvant hormonal therapy (NHT) is defined as therapy given before definitive local curative treatment.\nSince PCa is an androgen-dependent tumour, NHT is an appealing concept. A recent review and m",
"Synonmys":"Neoadjuvant and adjuvant hormonal therapy and radical prostatectomy",
"NCI_code":"NA"
},
{
"Name":"Radiation Therapy",
"Definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative trea",
"Synonmys":"Cancer Radiotherapy\nIrradiate\nIrradiated\nirradiated\nirradiation\nIrradiation\nRadiation\nRADIATION\nRadiation Therapy\nradiation therapy\nRadiotherapeutics\nRADIOTHERAPY\nradiotherapy\nRadiotherapy\nRT\nTherapy,",
"NCI_code":"NCI Thesaurus Code:C15313"
},
{
"Name":"External Beam Radiation Therapy",
"Definition":"Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.\/NCI-GLOSS Definition: A type of radiation therapy that uses a machine to aim high-energy rays at the c",
"Synonmys":"Definitive Radiation Therapy\nEBRT\nExternal Beam Radiation Therapy\nEXTERNAL BEAM RADIATION THERAPY\nExternal Beam Radiotherapy\nExternal Beam RT\nexternal radiation\nExternal Radiation Therapy\nexternal-bea",
"NCI_code":"NCI Thesaurus Code:C15751"
},
{
"Name":"Image Guided Radiation Therapy",
"Definition":"A procedure that uses a computer to create a picture of a tumor to help guide the radiation beam during radiation therapy. The pictures are made using CT, ultrasound, X-ray, or other imaging technique",
"Synonmys":"IGRT\nImage Guided Radiation Therapy\nimage-guided radiation therapy",
"NCI_code":"NCI Thesaurus Code:C62727"
},
{
"Name":"Three-dimensional conformal radiotherapy (3D-CRT)",
"Definition":"Anatomical data is acquired by scanning the patient in a treatment position. The data are transferred to the three-dimensional (3D) treatment planning system, which visualises the clinical target volu",
"Synonmys":"Three-dimensional conformal radiotherapy (3D-CRT)",
"NCI_code":"NA"
},
{
"Name":"Intensity-Modulated Radiation Therapy",
"Definition":"An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than ",
"Synonmys":"IMRT\nIntensity Modulated RT\nIntensity-Modulated Radiation Therapy\nintensity-modulated radiation therapy\nINTENSITY-MODULATED RADIATION THERAPY\nIntensity-Modulated Radiotherapy",
"NCI_code":"NCI Thesaurus Code:C16135 "
},
{
"Name":"Immediate post-operative external irradiation afte",
"Definition":"NA",
"Synonmys":"Immediate post-operative external irradiation after RP",
"NCI_code":"NA"
},
{
"Name":"Adjuvant post-operative external irradiation after",
"Definition":"NA",
"Synonmys":"Adjuvant post-operative external irradiation after RP",
"NCI_code":"NA"
},
{
"Name":"Proton beam therapy",
"Definition":"In theory, proton beams are an attractive alternative to photon-beam radiotherapy for PCa, as they\ndeposit almost all their radiation dose at the end of the particle’s path in tissue (the Bragg peak),",
"Synonmys":"Proton beam therapy",
"NCI_code":"NA"
},
{
"Name":"Scanning Proton Beam Therapy",
"Definition":"Proton beam radiation therapy in which magnets deflect and steer the proton beam. (Adapted from medicalphysicsweb)",
"Synonmys":"Scanning Proton Beam Therapy",
"NCI_code":"NCI Thesaurus Code:C104941"
},
{
"Name":"Scattering Proton Beam Therapy",
"Definition":"Proton beam radiation therapy in which the proton beam is spread by placing scattering material in the path of the protons. (Adapted from medicalphysicsweb)",
"Synonmys":"Scattering Proton Beam Therapy",
"NCI_code":"NCI Thesaurus Code:C104942"
},
{
"Name":"Radionuclide",
"Definition":"NA",
"Synonmys":"Radionuclide",
"NCI_code":"NA"
},
{
"Name":"Mopidamol",
"Definition":"A derivative of dipyridamole that is a phosphodiesterase inhibitor, with potential antiplatelet activity. Mopidamol inhibits the hydrolysis of cyclic nucleotides, such as cyclic adenosine monophosphat",
"Synonmys":"2,2',2\",2\"'-[(4-Piperidinopyrimido[5,4-d-]pyrimidine-2,6-diyl)dinitrilo]tetraethanol\n2,2',2\",2\"'-[[4-(1-Piperidinyl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo]tetrakisethanol\n2,6-Bis(diethanolamino)",
"NCI_code":"NCI Thesaurus Code:C668"
},
{
"Name":"St-89",
"Definition":"NA",
"Synonmys":"St-89",
"NCI_code":"NA"
},
{
"Name":"Radiotherapy for localised prostate cancer",
"Definition":"NA",
"Synonmys":"Radiotherapy for localised prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Dose Escalation",
"Definition":"A stepwise increase in the amount of a therapeutic or investigational agent given to an individual.",
"Synonmys":"Dose Escalation\nDose-Escalation",
"NCI_code":"NCI Thesaurus Code:C107213"
},
{
"Name":"External Beam Radiation Therapy",
"Definition":"Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.\nNCI-GLOSS Definition: A type of radiation therapy that uses a machine to aim high-energy rays at the c",
"Synonmys":"Definitive Radiation Therapy\nEBRT\nExternal Beam Radiation Therapy\nEXTERNAL BEAM RADIATION THERAPY\nExternal Beam Radiotherapy\nExternal Beam RT\nexternal radiation\nExternal Radiation Therapy\nexternal-bea",
"NCI_code":"NCI Thesaurus Code:C15751"
},
{
"Name":"Very high-risk prostate cancer EBRT",
"Definition":"NA",
"Synonmys":"Very high-risk prostate cancer EBRT",
"NCI_code":"NA"
},
{
"Name":"High-risk prostate cancer EBRT",
"Definition":"NA",
"Synonmys":"High-risk prostate cancer EBRT",
"NCI_code":"NA"
},
{
"Name":"Intermediate-risk prostate cancer EBRT",
"Definition":"NA",
"Synonmys":"Intermediate-risk prostate cancer EBRT",
"NCI_code":"NA"
},
{
"Name":"Low-risk prostate cancer EBRT",
"Definition":"NA",
"Synonmys":"Low-risk prostate cancer EBRT",
"NCI_code":"NA"
},
{
"Name":"Hypofractionated Radiation Therapy",
"Definition":"Radiation treatment in which the total dose of radiation is divided into large doses and treatments are given less than once a day.",
"Synonmys":"Hypofractionated Radiation Therapy\nhypofractionated radiation therapy\nHypofractionated Radiotherapy\nhypofractionation",
"NCI_code":"NCI Thesaurus Code:C62726"
},
{
"Name":"Lymph node irradiation",
"Definition":"NA",
"Synonmys":"Lymph node irradiation",
"NCI_code":"NA"
},
{
"Name":"Internal Radiation Therapy",
"Definition":"A type of radiation therapy in which radioactive material is placed inside the body, into a tumor or body cavity.\/NCI-GLOSS Definition: A type of radiation therapy in which radioactive material sealed",
"Synonmys":"BRACHYTHERAPY\nBrachytherapy\nbrachytherapy\ninternal radiation\nInternal Radiation\nInternal Radiation Brachytherapy\nInternal Radiation Therapy\nRadiation Brachytherapy\nradiation brachytherapy",
"NCI_code":"NCI Thesaurus Code:C15195"
},
{
"Name":"High-Dose Rate Brachytherapy",
"Definition":"Internal radiation treatment that targets a cancerous tissue with accurate, high doses of radiation through the use of inserted temporary implants.\/CDISC Definition: A type of brachytherapy that targe",
"Synonmys":"High-Dose Rate Brachytherapy\nHIGH-DOSE RATE BRACHYTHERAPY",
"NCI_code":"NCI Thesaurus Code:C15651"
},
{
"Name":"Iodine-125",
"Definition":"iodine-125 in granular form is the radioactive element of reference, while palladium-103 may be used for less differentiated tumours with a high doubling time. The doses delivered to the planning targ",
"Synonmys":"Iodine-125",
"NCI_code":"NA"
},
{
"Name":"Iridium Ir 192",
"Definition":"A radioactive isotope of iridium. Iridium-192 emits gamma rays and has a half-life of 74 days. A high dose rate of this radioisotope can be used in brachytherapy to treat tumors by selectively deliver",
"Synonmys":"Ir-192\nIridium Ir 192\nIRIDIUM IR-192\nIridium-192",
"NCI_code":"NCI Thesaurus Code:C104270"
},
{
"Name":"Low-Dose Rate Brachytherapy",
"Definition":"Internal radiation treatment that targets a cancerous tissue with low doses of radiation through the use of inserted temporary or permanent implants.\/CDISC Definition: A type of brachytherapy that tar",
"Synonmys":"LOW-DOSE RATE BRACHYTHERAPY\nLow-Dose Rate Brachytherapy",
"NCI_code":"NCI Thesaurus Code:C85254"
},
{
"Name":"Palladium Pd-103",
"Definition":"A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-en",
"Synonmys":"Palladium Pd 103\nPalladium Pd-103\nPalladium-103\nPd 103\nradioactive palladium",
"NCI_code":"NCI Thesaurus Code:C2550"
},
{
"Name":"Side effects of percutaneous irradiation and brach",
"Definition":"Radiotherapy affects erectile function to a lesser degree than surgery, according to retrospective surveys of patients. A meta-analysis has shown that the 1-year probability rates for maintaining erec",
"Synonmys":"Side effects of percutaneous irradiation and brachytherapy",
"NCI_code":"NA"
},
{
"Name":"Other radiotherapy",
"Definition":"NA",
"Synonmys":"Other radiotherapy",
"NCI_code":"NA"
},
{
"Name":"Neoadjuvant chemotherapy plus radiotherapy",
"Definition":"The GETUG 12 trial investigated the impact of neoadjuvant chemotherapy with docetaxel on the PFS in a\ncohort of 413 high-risk patients, defined as having one or more of the following criteria: T3-4, G",
"Synonmys":"Neoadjuvant chemotherapy plus radiotherapy",
"NCI_code":"NA"
},
{
"Name":"Neoadjuvant or adjuvant hormone therapy plus radio",
"Definition":"The combination of radiotherapy with LHRH ADT has definitively proven its superiority compared with\nradiotherapy alone followed by deferred ADT on relapse, as shown by phase III randomised trials (Tab",
"Synonmys":"Neoadjuvant or adjuvant hormone therapy plus radiotherapy",
"NCI_code":"NA"
},
{
"Name":"Most Common Complication After Radiotherapy for Pr",
"Definition":"A question about an individual's knowledge of the most common complication after radiotherapy for prostate cancer.",
"Synonmys":"Most Common Complication After Radiotherapy for Prostate Cancer",
"NCI_code":"NCI Thesaurus Code:C124808 "
},
{
"Name":"Long-term complications after radiotherapy",
"Definition":"NA",
"Synonmys":"Long-term complications after radiotherapy",
"NCI_code":"NA"
},
{
"Name":"Short-term complications after radiotherapy",
"Definition":"NA",
"Synonmys":"Short-term complications after radiotherapy",
"NCI_code":"NA"
},
{
"Name":"Cryotherapy",
"Definition":"The therapeutic use of cold or refrigeration in medicine.",
"Synonmys":"Cryotherapy\nCRYOTHERAPY\ncryotherapy",
"NCI_code":"NCI Thesaurus Code:C40030"
},
{
"Name":"Cryosurgical ablation of the prostate (CSAP)",
"Definition":"NA",
"Synonmys":"Cryosurgical ablation of the prostate (CSAP)",
"NCI_code":"NA"
},
{
"Name":"Hormone Therapy",
"Definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone\/hormones level.\/CTEP Definition: Cancer therapy, which incorporates hormonal manipulation (e.g., ",
"Synonmys":"Chemotherapy-Hormones\/Steroids\nendocrine therapy\nEndocrine Therapy\nHormonal Therapy\nHormonal therapy\nhormonal therapy\nHormone Therapy\nhormone therapy\nhormone treatment",
"NCI_code":"NCI Thesaurus Code:C15445"
},
{
"Name":"Castration",
"Definition":"Surgical removal of the ovaries or testes.\/NCI-GLOSS Definition: Surgical removal of the testicles (orchiectomy) or ovaries (oophorectomy) to stop the production of sex hormones. Decreasing the levels",
"Synonmys":"Castration\ncastration\nSurgical Castration\nsurgical castration",
"NCI_code":"NCI Thesaurus Code:C15198"
},
{
"Name":"Surgical Castration",
"Definition":"Surgical removal of the ovaries or testes.\/NCI-GLOSS Definition: Surgical removal of the testicles (orchiectomy) or ovaries (oophorectomy) to stop the production of sex hormones. Decreasing the levels",
"Synonmys":"Castration\ncastration\nSurgical Castration\nsurgical castration",
"NCI_code":"NCI Thesaurus Code:C15199"
},
{
"Name":"Medical Castration",
"Definition":"Refers to the use of drugs to suppress the function of the ovaries or testicles.",
"Synonmys":"medical castration\nMedical Castration",
"NCI_code":"NCI Thesaurus Code:C15743"
},
{
"Name":"Continuous hormonal therapy",
"Definition":"NA",
"Synonmys":"Continuous hormonal therapy",
"NCI_code":"NA"
},
{
"Name":"Intermittent hormonal therapy (ITH)",
"Definition":"NA",
"Synonmys":"Intermittent hormonal therapy (ITH)",
"NCI_code":"NA"
},
{
"Name":"Leuprolide",
"Definition":"A synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolid",
"Synonmys":"6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig)\n6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)\nleuprolide\nLeupro",
"NCI_code":"NCI Thesaurus Code:C62042"
},
{
"Name":"Triptorelin",
"Definition":"A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After ",
"Synonmys":"6-D-Tryptophan-LH-RH\n6-D-Tryptophanluteinizing Hormone-releasing Factor\nAY-25650\nCL-118,532\nDecapeptyl\nDetryptoreline\nTriptorelin\ntriptorelin\nTRIPTORELIN",
"NCI_code":"NCI Thesaurus Code:C1267"
},
{
"Name":"Goserelin",
"Definition":"A synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) with antineoplastic activity. Goserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors.",
"Synonmys":"6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide\nGOSERELIN\ngoserelin\nGoserelin\nICI-118630",
"NCI_code":"NCI Thesaurus Code:C1374"
},
{
"Name":"Degarelix",
"Definition":"A long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the an",
"Synonmys":"Degarelix\nDEGARELIX\ndegarelix\nFE200486\nFirmagon\nN-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino",
"NCI_code":"NCI Thesaurus Code:C48385"
},
{
"Name":"Anti-androgens",
"Definition":"These oral compounds are classified according to their chemical structure as:\n• steroidal, e.g. cyproterone acetate (CPA), megestrol acetate and medroxyprogesterone acetate;\n• non-steroidal or pure, e",
"Synonmys":"Anti-androgens",
"NCI_code":"NA"
},
{
"Name":"5a-Reductase Inhibition",
"Definition":"Treatment with a 5a-reductase inhibitor with the goal of suppressing the conversion of testosterone to dihydrotestosterone.",
"Synonmys":"5a-Reductase Inhibition",
"NCI_code":"NCI Thesaurus Code:C15526"
},
{
"Name":"Dutasteride",
"Definition":"A synthetic 4-azasteroid compound. Dutasteride competitively and specifically binds to isoenzymes 1 and 2 of 5 alpha-reductase, forming stable enzyme complexes and inhibiting the conversion of testost",
"Synonmys":"alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide\nAvodart\nAvolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-",
"NCI_code":"NCI Thesaurus Code:C47503"
},
{
"Name":"Finasteride",
"Definition":"A synthetic 4-azasteroid compound. Finasteride competitively binds to and inhibits steroid type II 5-alpha-reductase in the prostate gland, liver, and skin, thereby interfering with the enzymatic conv",
"Synonmys":"(5alpha,17beta)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide\nChibro-Proscar\nFinasteride\nFINASTERIDE\nfinasteride\nFinastid\nMK 906\nPro-Cure\nPropecia\nPropeshia\nProscar\nProstide\nUrprosan",
"NCI_code":"NCI Thesaurus Code:C1099"
},
{
"Name":"Non-steroidal anti-androgens",
"Definition":"Non-steroidal anti-androgens monotherapy have been promoted on the basis of improved quality of life (QoL) and compliance compared to castration. They do not suppress testosterone secretion and it is ",
"Synonmys":"Non-steroidal anti-androgens",
"NCI_code":"NA"
},
{
"Name":"Bicalutamide",
"Definition":"A synthetic, nonsteroidal antiandrogen. Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bi",
"Synonmys":"(+\/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide\n4'-Cyano-alpha,alpha,alpha-trifuloro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide\n4-Cya",
"NCI_code":"NCI Thesaurus Code:C1599"
},
{
"Name":"Flutamide",
"Definition":"A toluidine derivative and a nonsteroidal antiandrogen that is structurally related to bicalutamide and nilutamide. Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively blo",
"Synonmys":"2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide\n4'-Nitro-3'-trifluoromethylisobutyranilide\nAlpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide\nApimid\nCebatrol\nChimax\nCytomid\nDro",
"NCI_code":"NCI Thesaurus Code:C509"
},
{
"Name":"Nilutamide",
"Definition":"A synthetic, nonsteroidal agent with antiandrogenic properties. Nilutamide preferentially binds to androgen receptors and blocks androgen receptor activation by testosterone and other androgens; this ",
"Synonmys":"1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione\n5,5-Dimethyl-3-[4-nitro-3-(trifluoro-methyl)phenyl]-2,4-imidazolidinedione\nAnandron\nNilandron\nNilutamide\nNILUTAMIDE\nnilutamide\nR",
"NCI_code":"NCI Thesaurus Code:C1173"
},
{
"Name":"Enzalutamide",
"Definition":"An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from oth",
"Synonmys":"ASP9785\nBenzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-\nEnzalutamide\nENZALUTAMIDE\nMDV3100\nXtandi",
"NCI_code":"NCI Thesaurus Code:C71744"
},
{
"Name":"Steroidal anti-androgens",
"Definition":"These compounds are synthetic derivatives of hydroxyprogesterone. Their main pharmacological side-effects are secondary to castration, while gynaecomastia is quite rare. The non-pharmacological side e",
"Synonmys":"Steroidal anti-androgens",
"NCI_code":"NA"
},
{
"Name":"Cyproterone Acetate",
"Definition":"The acetate salt of a synthetic steroidal antiandrogen with weak progestational and antineoplastic activities. Cyproterone binds the androgen receptor (AR), thereby preventing androgen-induced recepto",
"Synonmys":"3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(Acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-\n6-Chloro-1b,2b-dihydro-17a-hydroxy-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione Acetate\nAnd",
"NCI_code":"NCI Thesaurus Code:C1059"
},
{
"Name":"Megestrol Acetate",
"Definition":"The acetate salt form of megestrol, a synthetic derivative of the naturally occurring female sex hormone progesterone with potential anti-estrogenic and antineoplastic activity. Mimicking the action o",
"Synonmys":"(9beta,10alpha)-17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione\n17 Alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione\n17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate\n17-Hydroxy-6-methylpregna",
"NCI_code":"NCI Thesaurus Code:C1156"
},
{
"Name":"Medroxyprogesterone Acetate",
"Definition":"A synthetic, acetate derivative of the sex hormone progesterone. Medroxyprogesterone 17-acetate (NCI04)\/NCI-GLOSS Definition: A drug used to prevent endometrial cancer. It is also used to treat menstr",
"Synonmys":"(6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione\n17-(Acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione\n17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione Acetate\n17Alpha-acetoxy-6alpha-methylprogestero",
"NCI_code":"NCI Thesaurus Code:C1155"
},
{
"Name":"Luteinising-hormone-releasing hormone agonists",
"Definition":"Long-acting LHRH agonists are currently the main forms of ADT. These synthetic analogues of LHRH, are delivered as depot injections on a 1-, 2-, 3-, 6-monthly, or yearly basis. After the first injecti",
"Synonmys":"Luteinising-hormone-releasing hormone agonists",
"NCI_code":"NA"
},
{
"Name":"Achievement of castration levels",
"Definition":"Chronic exposure to LHRH agonists results in the down-regulation of LHRH-receptors, suppressing LH and FSH secretion and therefore testosterone production. The castration level is usually obtained wit",
"Synonmys":"Achievement of castration levels",
"NCI_code":"NA"
},
{
"Name":"Flare-up phenomenon",
"Definition":"The ‘flare phenomenon’ might lead to detrimental effects such as increased bone pain, acute bladder outlet obstruction, obstructive renal failure, spinal cord compression, and cardiovascular death due",
"Synonmys":"Flare-up phenomenon",
"NCI_code":"NA"
},
{
"Name":"Luteinising-hormone-releasing hormone antagonists",
"Definition":"LHRH antagonists bind immediately and competitively to LHRH receptors in the pituitary gland. The effect is a rapid decrease in LH, FSH and testosterone levels without any flare. The practical shortco",
"Synonmys":"Luteinising-hormone-releasing hormone antagonists",
"NCI_code":"NA"
},
{
"Name":"Abarelix",
"Definition":"A synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to and blocks the gonadotropin releasing hormone receptor",
"Synonmys":"Abarelix\nabarelix\nABARELIX\nPlenaxis\nPPI-149\nR-3827",
"NCI_code":"NCI Thesaurus Code:C2015"
},
{
"Name":"Degarelix",
"Definition":"A long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the an",
"Synonmys":"Degarelix\nDEGARELIX\ndegarelix\nFE200486\nFirmagon\nN-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino",
"NCI_code":"NCI Thesaurus Code:C48385"
},
{
"Name":"New compounds (for the castrate resistant status o",
"Definition":"During castration, the occurrence of castration-resistant status (CRPC) is systematic. It is thought that it is mediated through two main overlapping mechanisms, which are androgen-receptor (AR)-indep",
"Synonmys":"New compounds (for the castrate resistant status only)",
"NCI_code":"NA"
},
{
"Name":"Abiraterone Acetate",
"Definition":"An orally active acetate sester form of the steroidal compound abiraterone with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase\/C",
"Synonmys":"17-(3-Pyridyl)-5,16-androstadien-3beta-acetate\nAbiraterone Acetate\nABIRATERONE ACETATE\nabiraterone acetate\nAndrosta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)-\nCB7630\nZytiga",
"NCI_code":"NCI Thesaurus Code:C68845"
},
{
"Name":" Enzalutamide",
"Definition":"An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from oth",
"Synonmys":"ASP9785\nBenzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-\nEnzalutamide\nENZALUTAMIDE\nMDV3100\nXtandi",
"NCI_code":"NCI Thesaurus Code:C71744"
},
{
"Name":"Therapeutic Estrogen",
"Definition":"A class of natural or synthetic hormones that binds to a cytoplasmic receptor and initiates translocation of the hormone-receptor complex to the nucleus of target cells of tissues rich in estrogen rec",
"Synonmys":"Oestrogens\nTherapeutic Estrogen",
"NCI_code":"NCI Thesaurus Code:C483"
},
{
"Name":"Diethylstilboesterol (DES)",
"Definition":"Early studies by the Veterans Administration (VACURG) tested oral Diesthylstilboesterol (DES) at 5 mg\/day. This dosage was associated with high cardiovascular morbidity and mortality, which was second",
"Synonmys":"Diethylstilboesterol (DES)",
"NCI_code":"NA"
},
{
"Name":"Strategies to counteract the cardiotoxicity of oes",
"Definition":"Two strategies have been attempted to neutralise oestrogen cardiotoxicity. Parenteral oestrogen (polyoestradiol phosphate) to avoid first-pass hepatic metabolism was as effective as CAB for survival, ",
"Synonmys":"Strategies to counteract the cardiotoxicity of oestrogen therapy",
"NCI_code":"NA"
},
{
"Name":"Testosterone-lowering therapy (castration)",
"Definition":"NA",
"Synonmys":"Testosterone-lowering therapy (castration)",
"NCI_code":"NA"
},
{
"Name":"Bilateral orchiectomy",
"Definition":"Bilateral orchiectomy, either total or subcapsular pulpectomy, is a simple, cheap and virtually complication-free surgical procedure. It is easily performed under local anaesthesia and is the quickest",
"Synonmys":"Bilateral orchiectomy",
"NCI_code":"NA"
},
{
"Name":"Castration Levels of Testosterone",
"Definition":"A finding of low concentrations of testosterone in a subject's serum that results from the use of surgical or chemical castration procedures.",
"Synonmys":"Castration Levels of Testosterone",
"NCI_code":"NCI Thesaurus Code:C129259"
},
{
"Name":"Chemotherapy",
"Definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.\/NCI-GLOSS Definition: Treatment with anticancer drugs.\/CTEP Definition: Non-systemic chemotherapy treatment (e.g., ",
"Synonmys":"Chemo\nChemotherapy\nchemotherapy\nChemotherapy (NOS)\nChemotherapy, Cancer, General",
"NCI_code":"NCI Thesaurus Code:C15632"
},
{
"Name":"Doxorubicin Hydrochloride",
"Definition":"The hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated conge",
"Synonmys":"14-Hydroxydaunorubicin Hydrochloride\n3-Hydroxyacetyldaunorubicin Hydrochloride\n5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy",
"NCI_code":"NCI Thesaurus Code:C1326"
},
{
"Name":"Cabazitaxel",
"Definition":"A semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel binds to and stabilizes tubulin, resulting in the inhibition of microtubul",
"Synonmys":"1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoate]\nCabazitaxel\ncabazi",
"NCI_code":"NCI Thesaurus Code:C66937"
},
{
"Name":"Cisplatin",
"Definition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups ",
"Synonmys":"(SP-4-2)-Diamminedichloroplatinum\nAbiplatin\nBlastolem\nBriplatin\nCDDP\nCis-diammine-dichloroplatinum\nCis-diamminedichloridoplatinum\nCis-diamminedichloro Platinum (II)\nCis-diamminedichloroplatinum\nCis-di",
"NCI_code":"NCI Thesaurus Code:C376"
},
{
"Name":"Docetaxel",
"Definition":"A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata. Docetaxel displays potent and broad antineoplastic properties; it binds to and stabili",
"Synonmys":"[2aR-[2a alphaa,4beta,4a beta,6beta,9alpha,(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-[[(1,1-dimethylethoxy)carbonyl]-amino]-alpha-hydroxybenzemepropanoic Acid 12b-(Acetyloxy)-12(ben",
"NCI_code":"NCI Thesaurus Code:C1526"
},
{
"Name":"Estramustine",
"Definition":"A synthetic molecule combining estradiol and nornitrogen mustard through a carbamate link. Estramustine and its major metabolite estramustine bind to microtubule-associated proteins (MAPs) and tubulin",
"Synonmys":"17beta-(estra-1,3,5(10)-triene-3,17-diol 3-(bis(2-chloroethyl)carbamate))\nestra-1,3,5(10)triene-317beta-diol 3-[N,N-bis-(2-chloroethyl)carbamate]\nEstradiol 3-[bis(2-chloroethyl)carbamate]\nestradiol 3-",
"NCI_code":"NCI Thesaurus Code:C479"
},
{
"Name":"Mitoxantrone",
"Definition":"An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, re",
"Synonmys":"1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione\n1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinone\nDihydroxyanthracenedione\nMitoxantron",
"NCI_code":"NCI Thesaurus Code:C62050"
},
{
"Name":"Prednisone",
"Definition":"A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates ",
"Synonmys":".delta.1-Cortisone\n1, 2-Dehydrocortisone\n1,2-Dehydrocortisone\n17,21-Dihydroxypregna-1,4-diene-3,11,20-trione\nAdasone\nCortancyl\nDacortin\nDeCortin\nDecortisyl\nDecorton\nDelta 1-Cortisone\nDelta-Dome\nDeltac",
"NCI_code":"NCI Thesaurus Code:C770"
},
{
"Name":"Sipuleucel-T",
"Definition":"A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of",
"Synonmys":"APC8015\nAPC8015 Vaccine\nPA2024 (PAP\/GM-CSF)-Loaded Dendritic Cell Vaccine\nProvenge\nSipuleucel-T\nsipuleucel-T\nSIPULEUCEL-T",
"NCI_code":"NCI Thesaurus Code:C1985"
},
{
"Name":"Other chemotherapy drugs",
"Definition":"NA",
"Synonmys":"Other chemotherapy drugs",
"NCI_code":"NA"
},
{
"Name":"Castration-Resistant Prostate Carcinoma",
"Definition":"Prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production.",
"Synonmys":"Castration-Resistant Prostate Cancer\nCastration-Resistant Prostate Carcinoma\nCRPC\nMetastatic Castration-Resistant Prostate Carcinoma",
"NCI_code":"NCI Thesaurus Code:C130234"
},
{
"Name":"Androgen deprivation in CRPC",
"Definition":"NA",
"Synonmys":"Androgen deprivation in CRPC",
"NCI_code":"NA"
},
{
"Name":"Assessing treatment outcome in CRPC",
"Definition":"NA",
"Synonmys":"Assessing treatment outcome in CRPC",
"NCI_code":"NA"
},
{
"Name":"Bone targeted therapies in metastatic CRPC",
"Definition":"NA",
"Synonmys":"Bone targeted therapies in metastatic CRPC",
"NCI_code":"NA"
},
{
"Name":"Common complications due to bone metastases",
"Definition":"Common complications due to bone metastases include bone pain, vertebral collapse or deformity, pathological fractures and spinal cord compression. Cementation is an effective treatment for painful sp",
"Synonmys":"Common complications due to bone metastases",
"NCI_code":"NA"
},
{
"Name":"Painful bone metastases",
"Definition":"Most patients with CRPC have painful bone metastases. External beam radiotherapy is highly effective ,even as a single fraction.",
"Synonmys":"Painful bone metastases",
"NCI_code":"NA"
},
{
"Name":"Bisphosphonates",
"Definition":"Bisphosphonates have been used to inhibit osteoclast-mediated bone resorption in CRPC and have proven to be highly effective in reducing bone pain. 643 patients who had CRPC [862] with bone metastases",
"Synonmys":"Bisphosphonates",
"NCI_code":"NA"
},
{
"Name":"Radium 223",
"Definition":"The only bone-specific drug that is associated with a survival benefit is alpharadin, a radium 223 a-emitter. In a large phase III trial (ALSYMPCA), 921 patients with symptomatic CRPC, who failed or w",
"Synonmys":"Radium 223",
"NCI_code":"NA"
},
{
"Name":"RANK ligand inhibitors",
"Definition":"Denosumab is a fully human monoclonal antibody directed against RANKL (receptor activator of nuclear factor\nκB ligand), a key mediator of osteoclast formation, function, and survival. In M0 CRPC, deno",
"Synonmys":"RANK ligand inhibitors",
"NCI_code":"NA"
},
{
"Name":"Hormonal drugs targeting the endocrine pathways in",
"Definition":"NA",
"Synonmys":"Hormonal drugs targeting the endocrine pathways in the pre-docetaxel space",
"NCI_code":"NA"
},
{
"Name":"Abiraterone",
"Definition":"A steroidal compound with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase\/C17,20 lyase complex; CYP17A1), a member of the cytochr",
"Synonmys":"17-(3-Pyridyl)androsta-5,16-dien-3beta-ol\nAbiraterone\nABIRATERONE\nCB 7598",
"NCI_code":"NCI Thesaurus Code:C77333"
},
{
"Name":"Enzalutamide",
"Definition":"An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from oth",
"Synonmys":"ASP9785\nBenzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-\nEnzalutamide\nENZALUTAMIDE\nMDV3100\nXtandi",
"NCI_code":"NCI Thesaurus Code:C71744"
},
{
"Name":"Non-hormonal therapy",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Docetaxel regimen",
"Definition":"A significant improvement in median survival of 2-2.5 months occurred with docetaxel-based chemotherapy\ncompared to mitoxantrone + prednisone therapy. The standard for first-line cytotoxic chemotherap",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Vaccine",
"Definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.\/CTEP Definition: A substance or group of substances admini",
"Synonmys":"Vaccine\nvaccine\nVaccine Therapy",
"NCI_code":"C923"
},
{
"Name":"Salvage treatment after first-line docetaxel",
"Definition":"All patients who receive docetaxel-based chemotherapy for CRPC will progress, thus, there have been many clinical trials investigating the role of salvage chemotherapy. Several groups have used second",
"Synonmys":"Salvage treatment after first-line docetaxel",
"NCI_code":"NA"
},
{
"Name":"Abiraterone Acetate",
"Definition":"An orally active acetate sester form of the steroidal compound abiraterone with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase\/C",
"Synonmys":"17-(3-Pyridyl)-5,16-androstadien-3beta-acetate\nAbiraterone Acetate\nABIRATERONE ACETATE\nabiraterone acetate\nAndrosta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)-\/CB7630\/Zytiga",
"NCI_code":"NCI Thesaurus Code:C68845"
},
{
"Name":"Cabazitaxel",
"Definition":"A semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel binds to and stabilizes tubulin, resulting in the inhibition of microtubul",
"Synonmys":"1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoate]\nCabazitaxel\ncabazi",
"NCI_code":"NCI Thesaurus Code:C66937"
},
{
"Name":"Enzalutamide",
"Definition":"An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from oth",
"Synonmys":"ASP9785\nBenzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-\nEnzalutamide\nENZALUTAMIDE\nMDV3100\nXtandi",
"NCI_code":"NCI Thesaurus Code:C71744"
},
{
"Name":"Metastatic Prostate Carcinoma",
"Definition":"A carcinoma that arises from the prostate gland and has spread to other anatomic sites.",
"Synonmys":"Metastatic Prostate Cancer\nMetastatic Prostate Carcinoma\nProstate Cancer Metastatic\nProstate Carcinoma Metastatic",
"NCI_code":"NCI Thesaurus Code:C8946"
},
{
"Name":"Combination therapies",
"Definition":"NA",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Complete androgen blockade (CAB)",
"Definition":"There are conflicting results from the many studies comparing CAB with monotherapy. The largest RCT in 1,286 M1b patients found no difference between surgical castration plus flutamide compared to sur",
"Synonmys":"Complete androgen blockade (CAB)",
"NCI_code":"NA"
},
{
"Name":"Immediate versus deferred androgen deprivation the",
"Definition":"There is no discussion regarding the introduction of IAD in symptomatic patients. However, there is still controversy concerning the best time to introduce hormonal therapy in asymptomatic metastatic ",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Intermittent versus continuous androgen deprivatio",
"Definition":"Long-term castration stimulates prostate cell apoptosis. After an average period of 24 months, the tumour relapses, characterised by a castrate-independent state of growth. Experimental data indicate ",
"Synonmys":"Intermittent versus continuous androgen deprivation therapy (IAD)",
"NCI_code":"NA"
},
{
"Name":"Potential other benefits of intermittent androgen ",
"Definition":"Other possible long-term benefits include bone protection and\/or a protective effect against the metabolic syndrome. Testosterone recovery is seen in most studies, leading to an intermittent castratio",
"Synonmys":"Potential other benefits of intermittent androgen deprivation",
"NCI_code":"NA"
},
{
"Name":"Practical aspects for intermittent androgen depriv",
"Definition":"The optimal thresholds at which ADT must be stopped or resumed are empirical. Nevertheless, several points are clear.\n• IAD is based on intermittent castration. Therefore, only drugs leading to castra",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Non-steroidal anti-androgen (NSAA) monotherapy",
"Definition":"A systematic review has been published comparing non-steroidal antiandrogen monotherapy to castration (either medical or surgical) by the Cochrane group. The key message is that use of non-steroidal a",
"Synonmys":"Non-steroidal anti-androgen (NSAA) monotherapy",
"NCI_code":"NA"
},
{
"Name":"Contraindications for various therapies",
"Definition":"NA",
"Synonmys":"Contraindications for various therapies",
"NCI_code":"NA"
},
{
"Name":"First-line hormonal treatment",
"Definition":"Primary ADT is the standard of care. There is no level 1 evidence to choose between an LHRH analogueor antagonist, except in patients with an impending spinal cord compression. In these patients, the ",
"Synonmys":"First-line hormonal treatment",
"NCI_code":"NA"
},
{
"Name":"Hormonal treatment combined with chemotherapy",
"Definition":"Two large RCT were conducted, one is fully published, the second one just presented recently,\nbut representing a cohort twice as large. They both compared ADT alone as standard with AT combined with\nu",
"Synonmys":"Hormonal treatment combined with chemotherapy",
"NCI_code":"NA"
},
{
"Name":"Prognostic factors",
"Definition":"NA",
"Synonmys":"Prognostic factors",
"NCI_code":"NA"
},
{
"Name":"Other treatment",
"Definition":"NA",
"Synonmys":"Other treatment",
"NCI_code":"NA"
},
{
"Name":"Management of prostate cancer in older men",
"Definition":"NA",
"Synonmys":"Management of prostate cancer in older men",
"NCI_code":"NA"
},
{
"Name":"Evaluating health status in senior adults",
"Definition":"With a median age at diagnosis of 68 years, PCa is generally a disease of men aged > 70 years. In the USA, the increase in men aged > 65 years will result in an estimated 70% increase in annual diagno",
"Synonmys":"Evaluating health status in senior adults",
"NCI_code":"NA"
},
{
"Name":"Evaluation of life expectancy, comorbidity and hea",
"Definition":"In localised disease, > 10 years life expectancy is considered mandatory for any benefit from local treatment. Life expectancy varies within each age group. This can be explained by comorbidity, which",
"Synonmys":"Evaluation of life expectancy, comorbidity and health status",
"NCI_code":"NA"
},
{
"Name":"Baseline screening using the G8 screening tool",
"Definition":"The International Society of Geriatric Oncology (SIOG) Prostate Cancer Working Group (PCWG) recommends that treatment for senior adults should be based on systematic evaluation of health status. The G",
"Synonmys":"Baseline screening using the G8 screening tool",
"NCI_code":"NA"
},
{
"Name":"Cognitive Impairment",
"Definition":"Definition: Diminished mental function.\/NICHD Definition: Diminished mental function.",
"Synonmys":"Cognitive Impairment",
"NCI_code":"NCI Thesaurus Code:C116921"
},
{
"Name":"Comorbidity",
"Definition":"The coexistence of two or more disease processes.\/NCI-GLOSS Definition: The condition of having two or more diseases at the same time.",
"Synonmys":"comorbidity\nComorbidity",
"NCI_code":"NCI Thesaurus Code:C16457"
},
{
"Name":"Independent daily activities",
"Definition":"The level of dependence in daily activities influences survival in senior adults. The Activities of Daily Living (ADL) scale rates accomplishment of basic activities of daily living, while the Instrum",
"Synonmys":"Independent daily activities",
"NCI_code":"NA"
},
{
"Name":"Malnutrition",
"Definition":"Definition: Inadequate nutrition resulting from poor diet, malabsorption, or abnormal nutrient distribution.\/NCI-GLOSS Definition: A condition caused by not getting enough calories or the right amount",
"Synonmys":"malnourished\nMalnutrition\nmalnutrition",
"NCI_code":"NCI Thesaurus Code:C3669"
},
{
"Name":"Specific aspects of prostate cancer treatment in o",
"Definition":"NA",
"Synonmys":"Specific aspects of prostate cancer treatment in older men",
"NCI_code":"NA"
},
{
"Name":"Advanced prostate cancer",
"Definition":"NA",
"Synonmys":"Advanced prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Hormone-sensitive metastatic prostate cancer",
"Definition":"ADT is the first-line treatment in hormone-sensitive metastatic PCa. The SIOG PCWG recommends evaluation of baseline bone mineral density and prevention of osteoporosis by calcium and vitamin D supple",
"Synonmys":"Hormone-sensitive metastatic prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Metastatic CRPC",
"Definition":"In metastatic CRPC, docetaxel is standard in fit and vulnerable older men, with comparable response and tolerance to younger patients. Tolerability has not been specifically studied in frail older men",
"Synonmys":"Metastatic CRPC",
"NCI_code":"NA"
},
{
"Name":"Localised prostate cancer",
"Definition":"NA",
"Synonmys":"Localised prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Antiandrogen Therapy",
"Definition":"A therapeutic regimen that utilizes pharmaceuticals to reduce serum levels of male sex hormones.\/NCI-GLOSS Definition: Treatment with drugs used to block production or interfere with the action of mal",
"Synonmys":"ADT\nAndrogen Deprivation Therapy\nAnti-androgen Therapy\nAnti-androgen Treatment\nAntiandrogen Therapy\nantiandrogen therapy\nAntiandrogen Treatment\nHormone Deprivation Therapy\nHormone-Deprivation Therapy",
"NCI_code":"NCI Thesaurus Code:C15481"
},
{
"Name":"Deferred treatment",
"Definition":"Many men with localised PCa will not benefit from definitive treatment, and ~45% of men with PSAdetected\nPCa are candidates for deferred management. In men with comorbidity and limited life\nexpectancy",
"Synonmys":"Deferred treatment",
"NCI_code":"NA"
},
{
"Name":"External Beam Radiation Therapy",
"Definition":"Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.\/NCI-GLOSS Definition: A type of radiation therapy that uses a machine to aim high-energy rays at the c",
"Synonmys":"Definitive Radiation Therapy\nEBRT\nExternal Beam Radiation Therapy\nEXTERNAL BEAM RADIATION THERAPY\nExternal Beam Radiotherapy\nExternal Beam RT\nexternal radiation\nExternal Radiation Therapy\nexternal-bea",
"NCI_code":"NCI Thesaurus Code:C15751"
},
{
"Name":"Minimally invasive therapies",
"Definition":"Minimally invasive energy-ablative therapies are being developed rapidly, but there is still a lack of evidence to support their use.",
"Synonmys":"Minimally invasive therapies",
"NCI_code":"NA"
},
{
"Name":"Radical Prostatectomy",
"Definition":"The surgical removal of all of the prostate as well as some surrounding tissue, including lymph nodes.\/NCI-GLOSS Definition: Surgery to remove the entire prostate. The two types of radical prostatecto",
"Synonmys":"Prostatovesiculectomy\nRadical Prostatectomy\nradical prostatectomy",
"NCI_code":"NCI Thesaurus Code:C15399"
},
{
"Name":"Options other than surgery and radiotherapy for th",
"Definition":"Besides radical prostatectomy (RP), external-beam radiation and brachytherapy, other modalities have emerged as therapeutic options in patients with clinically localised PCa. In this chapter, we will ",
"Synonmys":"Options other than surgery and radiotherapy for the primary treatment of localised prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Cryosurgery",
"Definition":"The use of extreme cold to damage or destroy a body part, pathway, or function. The procedure is performed using small cryogenic probes during surgery, and has recently been applied to solitary sporad",
"Synonmys":"cryoablation\nCryoablation\nCRYOABLATION\nCryosurgery\ncryosurgery\ncryosurgical ablation",
"NCI_code":"NCI Thesaurus Code:C15215"
},
{
"Name":"Complications of cryosurgery for primary treatment",
"Definition":"Erectile dysfunction occurs in about 80% of patients and this remains a consistent complication of the CSAP procedure, independent of the generation of the system used. The complication rates describe",
"Synonmys":"Complications of cryosurgery for primary treatment of prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Results of modern cryosurgery for prostate cancer",
"Definition":"The therapeutic results of cryotherapy have improved over time with the introduction of enhanced techniques such as gas-driven probes and transperineal probe placement, as used in third-generation cry",
"Synonmys":"Results of modern cryosurgery for prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Focal therapy of prostate cancer",
"Definition":"During the past two decades, there has been a trend towards earlier diagnosis of PCa as a result of greater public and professional awareness, leading to the adoption of both formal and informal scree",
"Synonmys":"Focal therapy of prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Patient selection for focal therapy",
"Definition":"The primary objective of treatment must be the eradication of measurable and biologically aggressive disease with minimal toxicity. However, although treatment is usually intended to be a single sessi",
"Synonmys":"Patient selection for focal therapy",
"NCI_code":"NA"
},
{
"Name":"Pre-therapeutic assessment of patients",
"Definition":"The high number of random and systematic errors associated with TRUS-guided random biopsy regimens means that this procedure is not sufficiently accurate for selecting candidates for focal therapy. Pe",
"Synonmys":"Pre-therapeutic assessment of patients",
"NCI_code":"NA"
},
{
"Name":"High-intensity focused ultrasound of the prostate ",
"Definition":"HIFU consists of focused ultrasound waves, emitted from a transducer, that cause tissue damage by mechanical and thermal effects as well as by cavitation. The goal of HIFU is to heat malignant tissues",
"Synonmys":"High-intensity focused ultrasound of the prostate (HIFU)",
"NCI_code":"NA"
},
{
"Name":"Photodynamic Therapy",
"Definition":"Use of light activated drugs (photosensitizing agents) to kill cancer cells.\/NCI-GLOSS Definition: Treatment with drugs that become active when exposed to light. These activated drugs may kill cancer ",
"Synonmys":"PDT\nPhotodynamic Therapy\nphotodynamic therapy\nPhotoradiation Therapy",
"NCI_code":"NCI Thesaurus Code:C15300"
},
{
"Name":"Radiofrequency ablation and electroporation",
"Definition":"NA",
"Synonmys":"Radiofrequency ablation and electroporation",
"NCI_code":"NA"
},
{
"Name":"Post-treatment quality of life in patients with lo",
"Definition":"Increased life expectancy in PCa makes post-treatment QoL a key issue. Health-related QoL (HRQoL) refers to the impact of disease and treatment on well-being and physical, emotional and social functio",
"Synonmys":"Post-treatment quality of life in patients with localised prostate cancer",
"NCI_code":"NA"
},
{
"Name":"Active surveillance and watchful waiting",
"Definition":"Although active surveillance (AS) and watchful waiting (WW) avoids treatment-related side effects, they carry an increased risk of psychological distress, which significantly affects HRQoL. Risk facto",
"Synonmys":"Active surveillance and watchful waiting",
"NCI_code":"NA"
},
{
"Name":"Complications of high-intensity focused ultrasound",
"Definition":"Urinary retention appears to be one of the most common side-effects of HIFU, developing in almost allpatients, with the mean interval of catheterization via a suprapubic tube varying between 12 and 35",
"Synonmys":"Complications of high-intensity focused ultrasound",
"NCI_code":"NA"
},
{
"Name":"External-beam radiotherapy and low-dose rate brach",
"Definition":"EBRT and I-125 low-dose rate (LDR) brachytherapy may cause urinary, sexual- and bowel dysfunction. Both methods can result in irritative voiding symptoms, such as urgency, frequency, and urge incontin",
"Synonmys":"Complications of high-intensity focused ultrasound",
"NCI_code":"NA"
},
{
"Name":"Radiotherapy toxicity",
"Definition":"Patients must be informed about acute and late genitourinary or gastrointestinal toxicity and the impact of irradiation on erectile function. In contemporary practice, the NCIC toxicity grading system",
"Synonmys":"External-beam radiotherapy and low-dose rate brachytherapy",
"NCI_code":"NA"
},
{
"Name":"Hormone Therapy",
"Definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone\/hormones level.\/CTEP Definition: Cancer therapy, which incorporates hormonal manipulation (e.g., ",
"Synonmys":"Chemotherapy-Hormones\nSteroids\nendocrine therapy\nEndocrine Therapy\nHormonal Therapy\nHormonal therapy\nhormonal therapy\nHormone Therapy\nhormone therapy\nhormone treatment",
"NCI_code":"NCI Thesaurus Code:C15445"
},
{
"Name":"Side-effects of hormonal therapy",
"Definition":"NA",
"Synonmys":"Side-effects of hormonal therapy",
"NCI_code":"NA"
},
{
"Name":"Hot Flashes or Flushes, CTCAE",
"Definition":"Hot Flashes or Flushes, CTCAE",
"Synonmys":"Hot Flashes or Flushes, CTCAE\nHot flashes\/flushes",
"NCI_code":"NCI Thesaurus Code:C104318"
},
{
"Name":"Sexual Function",
"Definition":"The bodily processes that include arousal, erection, orgasm, and ejaculation.",
"Synonmys":"Sexual Function",
"NCI_code":"NCI Thesaurus Code:C118256 "
},
{
"Name":"Other systemic side-effects of androgen-deprivatio",
"Definition":"They are frequent and may lead to significantly increased morbidity or even mortality.",
"Synonmys":"Other systemic side-effects of androgen-deprivation therapy",
"NCI_code":"NA"
},
{
"Name":"Cardiovascular morbidity",
"Definition":"Cardiovascular mortality is now the most common cause of death in PCa patients, even exceeding PCa mortality. Several studies showed that ADT, even after only 6 months, was associated with an increase",
"Synonmys":"Cardiovascular morbidity",
"NCI_code":"NA"
},
{
"Name":"Fatigue",
"Definition":"Overall tiredness and lack of energy.\/CTCAE Definition: A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activiti",
"Synonmys":"Fatigue\nFATIGUE\nfatigue\nLack of Energy",
"NCI_code":"NCI Thesaurus Code:C3036"
},
{
"Name":"Metabolic effects",
"Definition":"Lipid alterations are common and may occur as early as the first 3 months of treatment. ADT also decreases insulin sensitivity and increases fasting plasma insulin levels, which is a marker of insulin",
"Synonmys":"Metabolic effects",
"NCI_code":"NA"
},
{
"Name":"Non-metastatic bone fractures",
"Definition":"Due to increased bone turnover and decreased BMD in a time-dependent manner, ADT use is linked to an increased risk of fracture (up to 45% relative risk with long-term ADT). Hip fractures in men are a",
"Synonmys":"Non-metastatic bone fractures",
"NCI_code":"NA"
},
{
"Name":"Radical Prostatectomy",
"Definition":"The surgical removal of all of the prostate as well as some surrounding tissue, including lymph nodes.\/NCI-GLOSS Definition: Surgery to remove the entire prostate. The two types of radical prostatecto",
"Synonmys":"Prostatovesiculectomy\nRadical Prostatectomy\nradical prostatectomy",
"NCI_code":"NCI Thesaurus Code:C15399"
},
{
"Name":"Treatment of PSA-only recurrence after treatment w",
"Definition":"Primary curative procedures such as RP, and RT are well-established therapeutic options in the management of localised PCa. Despite technical improvements, there is still a significant risk of cancer ",
"Synonmys":"Treatment of PSA-only recurrence after treatment with curative intent",
"NCI_code":"NA"
},
{
"Name":"Assessment of metastases",
"Definition":"NA",
"Synonmys":"Assessment of metastases",
"NCI_code":"NA"
},
{
"Name":"Assessment of local recurrences",
"Definition":"NA",
"Synonmys":"Assessment of local recurrences",
"NCI_code":"NA"
},
{
"Name":"Local recurrence after radiation therapy",
"Definition":"In patients with biochemical failure after radiation therapy, the biopsy status is a major predictor of outcome,provided the biopsies are obtained 18-24 months after treatment. Given the morbidity of ",
"Synonmys":"Local recurrence after radiation therapy",
"NCI_code":"NA"
},
{
"Name":"Local recurrence after radical prostatectomy",
"Definition":"The precise localisation of the local recurrence by imaging techniques is needed only if histological proof of the recurrence is mandatory before salvage treatment and\/or if this localisation could ch",
"Synonmys":"NA",
"NCI_code":"NA"
},
{
"Name":"Bone scan and abdominopelvic computed tomography",
"Definition":"The standard workup to detect PCa metastases usually includes bone scan and abdominopelvic CT. However,because biochemical failure after RP or radiation therapy precedes clinical metastases by 7-8 yea",
"Synonmys":"Bone scan and abdominopelvic computed tomography",
"NCI_code":"NA"
},
{
"Name":"Positron Emission Tomography and Computed Tomograp",
"Definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose ",
"Synonmys":"PET-CT Scan\nPET\/CT SCAN\nPositron Emission Tomography and Computed Tomography Scan\nPositron Emission Tomography\/Computed Tomography",
"NCI_code":"NCI Thesaurus Code:C103512"
},
{
"Name":"Other radionuclide techniques",
"Definition":"A 111In-capromab pendetide scan (ProstaScint™) yielded disappointing results in patients with biochemical failure after RP or radiation therapy. Its use is therefore not recommended.18F-Fluoride PET a",
"Synonmys":"Other radionuclide techniques",
"NCI_code":"NA"
},
{
"Name":"Whole-body and axial magnetic resonance imaging (M",
"Definition":"Diffusion-weighted whole-body MRI and the so-called axial MRI (evaluation of the spine and the pelvi-femoral area only) are more sensitive than bone scan and targeted radiographs and seem equally effe",
"Synonmys":"Whole-body and axial magnetic resonance imaging (MRI)",
"NCI_code":"NA"
},
{
"Name":"Management of PSA failures after radiation therapy",
"Definition":"Therapeutic options in these patients are ADT or local procedures such as SRP, cryotherapy, interstitial brachytherapy and high-intensity focused US . As a general rule, strong recommendations regardi",
"Synonmys":"Management of PSA failures after radiation therapy",
"NCI_code":"NA"
},
{
"Name":"Salvage radical prostatectomy (SRP)",
"Definition":"Salvage radical prostatectomy after RT has the longest history and best likelihood of local control relative to other salvage treatments. However, this must be weighed against the possible adverse eve",
"Synonmys":"Salvage radical prostatectomy (SRP)",
"NCI_code":"NA"
},
{
"Name":"Natural history of biochemical failure",
"Definition":"Once a PSA relapse has been diagnosed, it is important to determine whether the recurrence has developed at local or distant sites. The risk of subsequent metastases and PCSM may be predicted by the i",
"Synonmys":"Natural history of biochemical failure",
"NCI_code":"NA"
},
{
"Name":"Post-radical prostatectomy biochemical recurrence",
"Definition":"According to Pound et al., not all patients with BCF after RP develop clinical recurrence. The authors evaluated the follow-up data for 1,997 patients after RP, and only 34% of those with BCF subseque",
"Synonmys":"Post-radical prostatectomy biochemical recurrence",
"NCI_code":"NA"
},
{
"Name":"Post-radiotherapy biochemical recurrence",
"Definition":"Similar to patients experiencing PSA-recurrence after RP, patients with a PSA-rise following RT can be subdivided into prognostic categories. A high-risk subgroup with elevated risk of metastases and ",
"Synonmys":"Post-radiotherapy biochemical recurrence",
"NCI_code":"NA"
},
{
"Name":"Observation",
"Definition":"Watching something and taking note of what happens.\/CDISC Definition: Watching something and taking note of what happens.",
"Synonmys":"Observation\nOBSERVATION\nObservational",
"NCI_code":"NCI Thesaurus Code:C25598"
},
{
"Name":"Salvage brachytherapy for radiotherapy failure",
"Definition":"Following local recurrence after previous definitive RT there is no indication for external beam salvage RT as the total dose is limited and therefore the chance of cure is low. For carefully selected",
"Synonmys":"Salvage brachytherapy for radiotherapy failure",
"NCI_code":"NA"
},
{
"Name":"Salvage cryoablation of the prostate",
"Definition":"NA",
"Synonmys":"Salvage cryoablation of the prostate",
"NCI_code":"NA"
},
{
"Name":"Oncological outcomes",
"Definition":"In cases in which RT fails, salvage cryoablation of the prostate (SCAP) has been proposed as an alternative to SRP, as it has a potentially lower risk of morbidity and equal efficacy. However, the ver",
"Synonmys":"Oncological outcomes",
"NCI_code":"NA"
},
{
"Name":"Morbidity",
"Definition":"According to Cespedes et al., the risks of urinary incontinence and erectile dysfunction at least 12 months\nafter SCAP were as high as 28% and 90%, respectively. In addition, 8-40% of patients reporte",
"Synonmys":"Morbidity",
"NCI_code":"NA"
},
{
"Name":"Salvage High-intensity focused ultrasound (HIFU)",
"Definition":"NA",
"Synonmys":"Salvage High-intensity focused ultrasound (HIFU)",
"NCI_code":"NA"
},
{
"Name":"Treatment of PSA-only recurrences",
"Definition":"The timing and mode of treatment for PSA-only recurrences after RP or RT are still controversial.",
"Synonmys":"Treatment of PSA-only recurrences",
"NCI_code":"NA"
},
{
"Name":"Hormonal therapy",
"Definition":"Currently there is no available RCT comparing the effect of salvage ADT, although retrospective comparative\nstudies are available. Still, salvage ADT is often used and represents one major practice of",
"Synonmys":"Hormonal therapy",
"NCI_code":"NA"
},
{
"Name":"Observation",
"Definition":"Watching something and taking note of what happens.\/CDISC Definition: Watching something and taking note of what happens.",
"Synonmys":"Observation\nOBSERVATION\nObservational",
"NCI_code":"NCI Thesaurus Code:C25598"
},
{
"Name":"Radiation Therapy",
"Definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative trea",
"Synonmys":"Cancer Radiotherapy\nIrradiate\nIrradiated\nirradiated\nirradiation\nIrradiation\nRadiation\nRADIATION\nRadiation Therapy\nradiation therapy\nRadiotherapeutics\nRADIOTHERAPY\nradiotherapy\nRadiotherapy\nRT\nTherapy,",
"NCI_code":"NCI Thesaurus Code:C15313"
},
{
"Name":"Adjuvant radiotherapy (ART)",
"Definition":"Radiation therapy that is administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence.",
"Synonmys":"Adjuvant Radiotherapy",
"NCI_code":"NCI Thesaurus Code:C101642 "
},
{
"Name":"Salvage radiotherapy (SRT)",
"Definition":"Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or ",
"Synonmys":"SALVAGE\nSalvage Therapy\nsalvage therapy",
"NCI_code":"NCI Thesaurus Code:C15359 "
}
]
}